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Pulmonary diseases are major causes of death and disability on a global scale. In 2016, 
chronic obstructive pulmonary disease (COPD) was the 3rd most frequent cause of 
death in the world (1). It was the cause of approximately 2.9 million deaths, which was 
an increase of 5.5% since 2006. 63.4 million disability-adjusted life-years (DALYs) 
were lost to COPD in 2016, an increase of 6.5% over the last ten years (2). Cancers of 
the lower respiratory tract were the cause of 1.7 million deaths in 2016 (1). This made 
it the 6th most frequent cause of death globally, with an increase in deaths of 18% since 
2006. Respiratory cancers caused 36.4 million DALYs to be lost, an increase of 13.7% 
(2). Interstitial pulmonary diseases (ILDs) are not as prevalent as COPD and 
respiratory cancers, causing 127.500 deaths and 2.7 million DALYs lost in 2016, but 
they have an increasing impact on the global burden of disease, with a 40.4% increase 
in deaths and 32.6% increase in DALYs lost due to ILDs in the 2006-2016-period. 
In order to better prevent, treat and manage respiratory diseases, we need improved 
tools for assessing the state of the lung in both epidemiological research, clinical trials 
and clinical settings. We need to know that these tools are reliable, and that they give 
us results that are valid in the setting in which they are used. We also need to have 
reference materials consisting of healthy samples, in order to evaluate the results from 
those with disease or suspected disease. In thoracic medicine, tests of pulmonary 
function play a key role in diagnosis and management, together with radiological 
examinations, nuclear medicine examinations and invasive procedures such as 
bronchoscopy. 
Exchange of oxygen from the surrounding atmosphere to the blood and of carbon 
dioxide the other way, is the role of the lung. In order to achieve this, they have to 
conduct air from outside the organism through the conducting airways, into the parts 
of the lung where gas exchange between alveolar gas and blood can take place. Lung 
function can be divided into gas exchange, which is a passive process facilitated by 
means of diffusion, and ventilation of the regions of the lung where gas exchange can 
take place. Ventilation is an active process, regulated by the central nervous system, 
and performed by the respiratory muscles which are contracting to expand the thorax 
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and the lung during inhalation, and relaxing during exhalation. Although the 
respiratory muscles are what performs the ventilation of the lung, the state of the 
conducting airways is the main limiter of effective ventilation. Gas exchange therefore 
relies on lung ventilation and is affected by diseases which hamper air movement 
through the conducting airways. But gas exchange is also dependent on conditions 
only affecting the diffusion of gas molecules between alveolar gas and blood without 
interfering with ventilation. 
A number of different tests are in use to evaluate lung function in patients with 
respiratory symptom, to clarify which aspects of lung function is causing the 
symptoms and impairments, and to determine the severity of disease. These tests have 
different strengths and limitations, and they differ also in how well defined their 
normal values are. 
Better quality of clinical tests and understanding of the normal variation of their values 
are important to improve diagnostics and management of diseases of the lung, and in 
that way also improving future lung health care. 
A key pulmonary function test (PFT) is the measurement of the diffusing capacity of 
the lung. However, as compared to the most commonly used PFT, spirometry, there 
are far less data available as to the change of gas diffusing capacity throughout life, 
factors influencing its level and its relationship to other clinical data.  
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Abstract 
Pulmonary gas exchange oxygenates our blood and facilitates transfer of carbon 
dioxide produced out of the body. Measurement of pulmonary gas exchange by 
diffusing capacity of the lung for carbon monoxide (DLCO) shows a relatively large 
variability compared to other lung function measurements.  
DLCO is reduced by about 10 % in male test subjects 2-6 hours after exercise, which 
can contribute to measurement variability if it is not taken into consideration. The 
mechanisms behind post-exercise reduction in DLCO are not fully understood. 
We hypothesized that cutaneous vasodilation due to thermoregulation contributes to 
reducing pulmonary capillary blood volume after exercise, and thus reduction in DLCO 
due to less haemoglobin being able to bind oxygen in the lung. 
12 subjects, 6 women, went through an experimental protocol of baseline 
measurements of DLCO, mean surface temperature and cutaneous vascular 
conductance, and then a bout of exercise on a stationary bike to exhaustion. DLCO-
measurements were repeated after 90 minutes. They were then exposed to cold air to 
induce vasoconstriction, after which measurements were repeated. The participants 
acted as their own controls by going through the entire experiment except the cold 
exposure, on a different day. 
DLCO was reduced by 10% in the men, and 5% in the women, 90 minutes post-
exercise. Mean surface temperature and cutaneous vascular conductance were at the 
same level as at baseline. Exposure to cold air induced a cutaneous vasoconstriction, 
but DLCO remained at the same level. 
Post-exercise cutaneous hemodynamics and thermoregulation does not seem to 
contribute to the reduction in DLCO in the late recovery phase after exercise. 
In addition to challenges due to the relatively large measurement variability, little is 
known about the normal trajectory of DLCO-values throughout life, what causes 
change in DLCO over time, and what impact change in DLCO has on respiratory 
symptoms. 
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We wanted to model the change in DLCO over time in a general population sample and 
investigate possible predictors of different trajectories and we wanted to investigate 
whether the change in DLCO has any impact on dyspnoea in a general population 
sample. 
830 participants in the Hordaland County Cohort Study provided two measurements of 
DLCO and forced spirometry 9 years apart. Blood samples were analysed for 
haemoglobin and carboxyhaemoglobin. We also recorded age, height, weight, 
smoking status, accumulated tobacco smoke exposure, occupational exposure to dust 
and gas, education level and level of dyspnoea. 
Mean change in DLCO was -0.025 mmol ∙ min-1 ∙ kPa-1 ∙ year-1. We found that the 
decline accelerated with higher age. Smoking was a predictor for a more rapid decline 
in DLCO, and there was a dose-response-relationship between accumulated tobacco 
smoke exposure and rate of decline in DLCO. 
The decline in DLCO was associated with an increase in dyspnoea score in men. We 
found no such association for women. An interaction between age and change in DLCO 
was observed in both men and women, with a more severe increase in dyspnoea per 
unit of decline in DLCO with higher age. 
In a general population sample observed over 9 years, the rate of decline in DLCO 
accelerated with higher age. Smoking was associated with a more rapid decline. An 
association between decline in DLCO and increase in dyspnoea was observed in the 
men, but not in the women. 
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1. Background 
1.1 Definition of diffusing capacity 
Diffusing capacity of the lung (DL) is a measurement of how many gas molecules are 
transported from the alveolar gas to the blood per unit of time per unit of driving 
pressure. Diffusing capacity is measured in mmol · min-1 · kPa-1 or in mL · min-1 · 
mmHg-1. The driving pressure is the partial pressure gradient across the 
alveolocapillary membrane for the gas in question. 
Capacity may be a somewhat imprecise term in this regard, as we are measuring the 
rate of gas exchange at rest in standardised test conditions, and not the maximum 
capacity. The term transfer factor has also been used for the measurement of gas 
exchange, but the American Thoracic Society (ATS) and the European Respiratory 
Sociaty (ERS) task force for standardisation of lung function testing have agreed upon 
using the term diffusing capacity in their reports (3). 
1.2 Physiology in normal conditions 
Oxygen rich air is inhaled, and the oxygen molecules reaches the alveoli in the lung. 
The alveolocapillary membrane is permeable to gas molecules, and consists of only 
two layers of cells, with a common basal membrane, making the distance between the 
alveolar air and capillary blood small enough for effective diffusion. Oxygen 
molecules diffuse along the partial pressure gradient, from the oxygen rich inhaled air, 
to the oxygen poor blood in the pulmonary capillaries. The oxygen is dissolved in the 
blood plasma and is then quickly bound to haemoglobin molecules in the erythrocytes. 
Almost all of the oxygen in the blood is bound to haemoglobin, but the pressure 
gradient is between the alveolar air and the dissolved oxygen in plasma. One could say 
that haemoglobin is a sink to the oxygen in plasma and keeps the gradient high, until 
all the haemoglobin molecules are saturated and equilibrium is reached. 
The surface area of the alveolocapillary membrane is also a key to the effectiveness of 
pulmonary gas exchange. The lung consists of hundreds of millions of alveoli (4). 
Together they provide a large surface area over which gas exchange can take place. 
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Carbon dioxide produced in the tissues, is transported back to the lung in the blood. It 
also is also mostly bound to haemoglobin, with only a small fraction of about 5-10% 
dissolved freely in plasma. In the pulmonary capillaries, carbon dioxide diffuses the 
opposite way of oxygen, because of the lower partial pressure of carbon dioxide in the 
alveolar gas. It then leaves the organism during exhalation.  
1.3 Measuring diffusing capacity 
Oxygen is the gas of interest in regard to lung-blood gas exchange. As stated above, 
the driving pressure is part of the unit of gas exchange, and therefore, in order to 
calculate diffusing capacity, the driving pressure has to be calculated. To do that 
calculation, partial pressure in alveolar gas and lung capillary blood has to be known. 
Oxygen levels in the blood returning to the lung from the tissues around the body 
show large variability (5). Carbon monoxide (CO) is therefore used as a substitute for 
oxygen, as CO can be assumed to be absent in blood, and because CO is bound by 
haemoglobin in the same way as oxygen. Diffusing capacity of the lung for carbon 
monoxide (DLCO) has become a standard measurement of pulmonary gas exchange in 
thoracic medicine, and the single breath-method is the most commonly used method to 
measure DLCO (3). 
Single breath DLCO is measured with the test subject breathing through the test 
apparatus, with the following procedure: 
1. Tidal breathing 
2. Exhalation to residual volume (RV) 
3. A valve in the testing apparatus switches to allow inhalation of the test gas 
4. Inhalation to total lung capacity (TLC) 
5. 10 seconds breath hold 
6. Exhalation 
7. Exhaled gas is analysed for concentration of the test gases 
The test gas contains a known concentration of CO. However, inhaled test gas mixes 
with the air left in the lung after full exhalation, the residual volume, and is diluted 
into a lower partial pressure. In order to calculate the diffusing constant for carbon 
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monoxide, KCO, we need to calculate the volume of gas containing CO in the lung, 
termed alveolar volume (VA), to find the partial pressure of CO after dilution which 
will also be the driving pressure. This is done by adding a biologically and chemically 
inert tracer gas, which also has to be relatively insoluble, to the test gas. Helium and 
methane (CH4) are the most frequently used tracer gases. They are diluted in the RV, 
but stay in the lung, and as we know the concentration of the tracer gas in the inhaled 
test gas (PI,Tr), and measure the inspired volume (VI) and concentration in the expired 
alveolar gas (PA,Tr), after discarding gas from the dead space where no gas exchange 
takes place,  VA can be calculated by the following formula after taking the volume of 
the dead space (VD), where no gas exchange takes place, into account: 









KCO is calculated as the fall in concentration of CO per unit of time per unit of driving 





In order to calculate lung diffusing capacity in terms of carbon monoxide uptake, KCO 
has to be multiplied by VA: 
𝐷𝐿./ = 𝐾./ × 𝑉" 
DLCO can be partitioned into two conductance components. Membrane conductivity 
(DM) represents the effectiveness of the alveolocapillary membrane in gas exchange. 
The vascular component represents the effectiveness of the pulmonary vascular system 
in binding CO to haemoglobin in blood and transporting it away. The vascular 
component is a product of the rate of chemical binding between CO and haemoglobin 
(q) and the amount of haemoglobin in alveolar capillary blood (VC). The relationship 
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Measurement of the membrane and vascular components of DLCO can be done by 
measuring DLCO twice, using two test gases with different partial pressures of oxygen. 
It is not done routinely. 
1.4 Pathophysiology of gas exchange 
Gas exchange can be reduced by several different mechanisms in disease. These are 
some examples, and some of the diseases of the lung impact gas exchange by several 
mechanisms. 
In obstructive pulmonary diseases and neuromuscular diseases, ventilation of the 
alveoli is reduced. Consequently, the driving pressure for gas exchange is reduced. 
Due to destruction of alveoli, the alveolar surface available for gas exchange is also 
reduced. 
Pulmonary embolism obstructs the pulmonary blood vessels, reducing lung perfusion 
and making less blood available to absorb inhaled oxygen. 
Alpha-1 antitrypsin deficiency causes destruction of alveoli by the enzyme neutrophil 
elastase, leading to a reduced surface area over which gas exchange can take place. 
Left-sided heart failure causes a chronic increase in pulmonary capillary wedge 
pressure, leading to a thickening of the alveolocapillary membrane. A longer distance 
between the alveolar air molecules and capillary blood results in a decrease in the rate 
of gas exchange. 
Reduced haemoglobin concentration in anaemia reduces the amount of oxygen that 
can be taken up per unit of blood volume, and in turn the rate of gas exchange. 
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Reduction in total lung volume, as can be seen after tuberculosis and lung cancer 
surgery, will of course also cause a reduction in diffusion capacity. 
1.5 DLCO in clinical use 
Measurement of DLCO is routinely used in thoracic clinics. Clinical guidelines 
recommend measuring DLCO in assessing and managing several diseases. 
National Institute for Health and Care Excellence (NICE) in the United Kingdom 
recommends measuring DLCO to assess severity and prognosis of COPD, as forced 
spirometry alone poorly reflects disability in patients with COPD (6). In patients with 
COPD and chronic respiratory failure, DLCO has been shown to be a prognostic marker 
independent of forced spirometry (7). 
DLCO has been found to be an important prognostic factor in idiopathic pulmonary 
fibrosis (8). NICE guidelines for diagnosis and management of idiopathic pulmonary 
fibrosis in adults recommend measuring DLCO at the time of diagnosis and at follow-
ups 6 and 12 months after diagnosis to assess the prognosis for these patients (9). 
In those undergoing lung resection, mainly due to lung cancer, DLCO has been shown 
to be a strong predictor of pulmonary complications after surgery (10), and 
measurement of DLCO is recommended to evaluate the risk of the procedure (11). 
1.6 Variability in DLCO 
1.6.1 Magnitude of variability 
Current guidelines on measurement on DLCO (3) states that the mean of two efforts 
with measured values no more than 10% apart should be reported as the subject’s 
DLCO. This means that variability of 10% is considered to be acceptable. 
Punjabi et al. (12) observed that 98% of a sample of over 6.000 patients who visited a 
general pulmonary function laboratory were able to meet the criteria of two efforts 
with values within 10% of each other. In healthy subjects, they observed a coefficient 
of variability between efforts of 3%. 
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Jensen et al. (13) performed repeated measurements of DLCO on healthy subjects over 
a 6-month period, using several of the apparatuses that were available on the market. 
They also performed repeated DLCO-measurements using a simulator in order to 
estimate instrument variability. Estimated coefficients of variability per instrument 
ranged from 5% to 10%, and instrument variability accounted for 36% to 70% of the 
observed variability. 
1.6.2 Sources of variability 
Physiological and pathological variability in available haemoglobin in the pulmonary 
capillaries influence the vascular component of DLCO. Total available haemoglobin per 
unit of time is dependent on blood haemoglobin concentration and cardiac output. 
Carbon monoxide is, as mentioned above, assumed not to be present in the blood when 
calculating DLCO, and the pressure gradient is assumed to be equivalent to the partial 
pressure of CO in the alveoli. This is not always the case. Cigarette smoking is the 
major source of CO in human blood. It binds with haemoglobin to form 
carboxyhaemoglobin, and causes a reduction in measured DLCO values (14). There is 
also a small endogenous production of CO in the body, mainly from catabolism of 
haeme groups of haemoglobin, which Coburn et al. estimated to 0.28-0.46mL · hour-1 
(15). With carbon monoxide density of about 40mmol/L at 1000hPa, endogenous 
production of CO amounts to about 0.01-0.02mmol · hour-1. Norwegian reference 
values for carboxyhaemoglobin state a carboxyhaemoglobin fraction of 0.018 as the 
upper limit of normal in non-smokers (16). 
Corrections for levels of haemoglobin and carboxyhaemoglobin can be made if they 
are measured (3). 
Diurnal variation in DLCO has been observed, but is attributed to diurnal variations in 
blood haemoglobin concentration and carboxyhaemoglobin and not how the lung 
function per se (17). 
Menstrual cycle variation of DLCO has been observed by Sansores et al. (18), with a 
9% difference between peak before menses, and nadir on day three of menstruation. 
Pulmonary capillary blood volume and haemoglobin concentrations were found to be 
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unchanged and could not explain the observed variability in that study. Farha et al. in 
contrast found a 25% decrease in pulmonary capillary blood volume, and also found a 
correlation between pulmonary capillary blood volume and proangiogenic factors 
related to the menstrual cycle (19). 
1.6.3 Impact of variability in DLCO 
In the study mentioned above Jensen et al. found a marked difference in the magnitude 
of variability between measurements of forced expiratory volume in 1 second (FEV1) 
and DLCO, with FEV1 coefficients of variance of 2.56 % to 4.24%. This makes it easier 
to detect changes and differences in FEV1 than in DLCO. In clinical settings, this means 
that a pulmonary fibrosis patient has to have a more severe worsening in her lung 
function in terms of DLCO before it can be identified, compared to the worsening in 
FEV1 for a COPD patient. In a research setting, it means that larger sample size is 
required to detect the same relative change or difference in DLCO than in FEV1, 
making it more demanding in terms of resources and more difficult in terms of 
recruiting participants to do research on gas exchange.  
1.7 Post-exercise reduction in DLCO 
Physical exercise induces a transient reduction in DLCO and can be a cause of day to 
day variability in DLCO. Sheel et al. (20) found a 10% reduction in DLCO 1-6 hours 
after maximal exercise. DLCO was back to baseline values after 24 hours. Submaximal 
exercise also has been found to induce a reduction in DLCO (21, 22), but of less 
magnitude than maximal exercise. 
In elite marathon runners, cyclists and triathletes, it has been found that hig intensity 
exercise can cause a subclinical pulmonary oedema (23-25). This could reduce DLCO 
due to a thickening of the alveolocapillary membrane. 
Pulmonary oedema has however not been found post-exercise in moderately trained 
individuals (26), or after submaximal exercise (27, 28), even though a post-exercise 
reduction in DLCO also is present in those cases. 
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Pulmonary capillary volume has been found to be decreased by 12 % one hour after 
exercise (25), and this significantly contributes to reduced DLCO. Hanel et al. also 
found a post-exercise reduction in intrathoracic blood volume by using transthoracic 
bioimpedance and technetium labelled erythrocytes (29). An increased number of 
erythrocytes in skeletal muscle was detected in that study, but not enough to account 
for the entire reduction in DLCO. 
None of the prior studies on post-exercise reduction in DLCO have included women. 
In thermoneutral conditions, skin blood volume amounts to about 2% of total blood 
volume (30). The skin plays a major role in thermoregulation of the body, and 
cutaneous blood volume increases when the body is heated (31). DLCO is influenced 
by the thermal status of the body (32). 
One could hypothesize that increased cutaneous blood volume due to elevated body 
temperature post-exercise could contribute to a reduction in the intrathoracic blood 
volume. 
1.8 DLCO in general population studies 
Several cross-sectional studies on DLCO in general population studies have been 
published. Some have studied factors associated with DLCO (33-35). Several studies 
have also been published to established reference values for DLCO in healthy subject, 
to be used to interpret observed values of patients in clinical settings. 
1.8.1 Normal trajectory of DLCO  
Reference values for DLCO are based on population studies with measurements of 
DLCO, and using regression models with several variables, such as sex and height, to 
estimate predicted values for each patient who is being examined at thoracic medical 
clinics. Reference equations for calculating predicted DLCO contain a coefficient for 
age, showing an estimated decrease in DLCO with ageing (36-40). A cross-sectional 
design is however inferior to a longitudinal design when trying to model change in 
DLCO with ageing. A cross-sectional study would in this situation be prone to 
generation effects. It could for instance be that older generations have different 
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trajectories in DLCO than the younger, due to changes in environmental and 
occupational exposure. This would lead to errors in interpretations of change in DLCO 
over time in a patient using extrapolated cross-sectional data, as is the situation today. 
Some longitudinal studies on trajectories of DLCO have been made with samples from 
specific populations, such as firefighters (41), middle aged men in London (42, 43), 
divers (44), patients with pulmonary fibrosis (45), pigeon breeders (46) and shipyard 
workers (47). The trajectories observed in these studies can however not be used to 
estimate trajectories in a general population. 
To our knowledge data from only two longitudinal studies on DLCO in general 
populations samples have been published.  
The Tucson Epidemiology Study of Obstructive Lung Disease observed 543 subjects 
with a mean observation time of 8 years, between 1982-1983 and 1990-1991. Sherrill 
et al. (48) found an acceleration in decline in DLCO with higher age. Smokers had a 
lower DLCO at baseline, but not a more rapid decline than non-smokers during the 
observation period.  
The Po River Delta Epidemiologic Study followed 928 subjects with a mean 
observation time of 8 years. Similarly to the Tucson study, Viegi et al. (49) found an 
accelerated decline in DLCO with higher age, and no association between smoking and 
rate of decline in DLCO. 
None of the prior longitudinal studies based on general population samples have 




The aims of this thesis were: 
1. To examine whether redistribution of blood from the thorax to the skin could be 
part of what causes the post-exercise reduction in DLCO.  
2. To describe the trajectory of change in DLCO in a general population sample, 
and to identify variables that predict different trajectories. 
3. To examine whether change in DLCO over time influences change in dyspnoea 
score. 
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3. Materials and Methods 
3.1 Physiological experiment 
3.1.1 Study design 
The study was approved by the regional ethics committee. It was designed as a 
controlled trial of a crossover design. Each participant went through the experiment 
twice, with and without the intervention, and were their own controls. 
The experiment consisted of baseline measurements, a bout of physical exercise on a 
cycle ergometer, 90 minutes of rest, post-exercise measurements, a cold exposure 
intervention to induce cutaneous vasoconstriction, and post-intervention 
measurements. In the control setting, the cold exposure was replaced by further resting 
for 30 minutes in thermoneutral conditions (figure 1). 
3.1.2 Study population 
A sample of 12 healthy subjects, six women, were recruited for the study. They were 
aged 20 to 27 years, exercised regularly, and were never-smokers. 
3.1.3 Pulmonary function testing 
Forced spirometry and measurement of single breath DLCO were performed on a 
Morgan Benchmark (PK Morgan Ltd, Kent, UK) lung function testing apparatus, with 
helium as a tracer gas. Measurements of DLCO were performed at baseline, 90 minutes 
post-exercise and post-intervention. Forced spirometry was only performed at 
baseline. Measurements were done in accordance with current guidelines (3). 
Figure 1. Study procedures overview 
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3.1.4 Skin temperature measurements 
Skin temperature was used to assess the thermal state of the subjects, and to validate 
the effect of the intervention. To estimate mean skin temperature (MST), the probes 
were placed in accordance with the method developed by Ramanathan (50), on the 
lateral part of the right calf, over the medial head of the right quadriceps, on the lateral 
part of the right biceps brachii and in the right mid-clavicular line 2.5cm below the 
clavicula. Rectal temperature was also recorded to make certain that the cold exposure 
did not affect the core temperature of the subjects, possibly inducing a general pressor 
response. 
 
3.1.5 Laser Doppler flowmetry 
Laser Doppler flowmetry was used to estimate cutaneous blood flow. The probes used 
for estimating mean skin temperature, also contained a laser emitter. We used one 
additional probe for the flowmetry, and this was placed 2cm below the right processus 
zygomaticus. The laser light penetrates 0.5-1.0mm into the skin. The probe detects the 
amount of light reflected from erythrocytes to give a representation of the amount of 
erythrocytes in the sampled skin volume, and the frequency shift in the light gives a 
representation of the velocity of the erythrocytes in the cutaneous blood vessels (51, 
52). Perfusion was monitored for 5 minutes to be certain that we were observing a 
steady state, but only the last minute was used for the analyses. The instrument reports 
perfusion in perfusion unit (PU), which is an arbitrary unit. Mean skin perfusion 
(MSP) was recorded as the mean of the values from all five probes. Heart rate and 
arterial blood pressure were measured along with the perfusion measurements. 
Cutaneous vascular conductance (CVC) was calculated as perfusion per mmHg of 
mean arterial blood pressure. 
3.1.6 Exercise protocol 
Exercise to induce the post-exercise reduction in DLCO was performed on a cycle 
ergometer, while monitoring heart rate with ECG and oxygen uptake by a 
Sensormedics Vmax Spectra 229 (Viasys Healthcare Inc., Conshohocken, PA, USA). 
Exercise started with a 5-minute warm up period, with a workload of 50 W for women 
and 70 W for men. After 5 minutes, the workload increased with 15 W per minute for 
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the women, and 20 W per minute for the men, and the subjects were asked to continue 
until exhaustion. 
3.1.7 Intervention 
After 90 minutes of rest in room temperature (21-22°C), and post-exercise 
measurements as detailed above, the subjects were exposed to cold air of 3-9°C 
outside the laboratory in order to induce surface cooling. We did not want to induce 
general hypothermia and shivering, so the cold exposure ended when the first 
uncontrolled muscle twitch was observed or reported by the subject. 
3.1.8 Statistical analyses 
Mean values from the intervention and control setting were compared using paired 
Student’s t-test, with the Bonferroni method to correct for multiple comparisons. A 
significance level of 5% was selected a priori. 
3.2 Hordaland County Cohort Study 
3.2.1 Study design 
The Hordaland County Cohort Study was an epidemiologic, prospective cohort study 
based on a general population sample. Recruiting started in 1985, with baseline data 
collection in 1987/1988, and follow-up in 1996/1997.  
3.2.2 Study population 
A random sample of 4,992 individuals from the Hordaland County, which had a total 
population of 267,304, were invited to answer a postal questionnaire in 1985. 3,370 
people responded. From the responders, a stratified sample of 1,512 subjects aged 18-
73 years, were invited to a baseline clinical examination. Stratification was done to 
ensure that the sample held a number of subjects with obstructive pulmonary disease, 
occupational exposure and asymptomatic non-smokers. The response rate was 84%, 
with 1,275 people attending baseline examination. 
DLCO measurements were obtained from 1,152 (90%) of those who attended the 
baseline study visit. 881 (76%) of those with DLCO measurements from the baseline 
visit, attended the follow-up visit in 1996/1997. 81 were lost to follow up because they 
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had moved out of the county, 63 withdrew consent, 23 had to withdraw due to serious 
illness, 43 were dead, and we were unable to establish contact with 61. DLCO values 
were obtained from 830 (94%) of those who attended the follow-up visit. Mean 
observation time was 9 years. 
3.2.3 Pulmonary function testing 
A Sensormedics Gould 2100 automated system (Sensormedics BV, Bilthoven, the 
Netherlands) was used for PFT. The instrument used at follow-up was the same that 
had been used at baseline, with the same calibration procedures, and biological 
controls were used throughout the observation time to ensure that measurements were 
not drifting. 
DLCO, along with KCO and VA, were measured using the single breath method, 
described above, with a breath-holding time of 10 seconds, a 750mL washout and a 
750mL sample volume. Helium was used as a tracer gas to calculate VA. Norsk Hydro 
A/S (Rjukan, Norway) delivered the test gas with certified concentrations of the gas 
mixture.  
Guidelines for measurement of DLCO require that subjects are able to achieve an 
inspiratory vital capacity (IVC) during the measurement that is at least 85% of their 
forced vital capacity (FVC). In our sample only 531 subjects (64%) were able to 
achieve this. Reducing the required IVC/FVC ratio to 0.7, meant that 750 subjects 
(90%) could be included. Analyses were performed both for those with an IVC/FVC 
ratio >=0.85 and those with a ratio >0.7, and the results were not significantly altered. 
It was therefore decided to use the analyses of subjects who were able to achieve a 
IVC/FVC ratio above 0.7. 
DLCO values were reported as the mean of two measurements, with no more than 10% 
variability. Norwegian reference equations for DLCO are based on the same population 
included in this study (36), and it would therefore not make sense to use those to 
calculate percent predicted values for DLCO. European reference values were used 
instead (53). 
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Forced spirometry with measurements of FEV1 and FVC were performed on the same 
apparatus as the DLCO measurements. Each subject had to perform three technically 
satisfactory efforts, with no more than 300mL difference between the two 
measurements with two values. Percent predicted FEV1 was calculated using 
Norwegian reference equations (54). 
All lung function measurements were performed in accordance with current guidelines 
at the time (53, 55-59) 
 
3.2.4 Additional measurements 
Height and weight were also recorded at each visit. Additionally, blood samples were 
drawn and analysed for haemoglobin concentration and fraction of 
carboxyhaemoglobin. 
3.2.5 Questionnaires 
Questionnaires were used to record smoking habits, including smoking status and 
cumulative tobacco smoke exposure, educational level and occupational exposure to 
dust or gas. The questionnaires have been described in detail by Bakke et al., Aanerud 
et al. and Welle et al. (60-62). 
3.2.6 Dyspnoea score 
Subjects were asked if they experienced dyspnoea, and if so if it occurred during rest, 
walking on level ground, walking two flights of stairs or walking uphill. The responses 
were translated into a dyspnoea score with a value of 0 being no dyspnoea, and 4 being 
dyspnoea at rest. 
3.2.7 Statistical analyses 
Independent samples t-test and exact chi-square test were used to compare those in the 
study to those lost to follow up. Independent samples t-test was also utilised in testing 
for cohort effects. Comparison of mean values from baseline and follow up was 
performed using paired samples t-test. Normal distribution testing was done using 
Kolmogorov-Smirnov and Shapiro-Wilk methods. A model for change in DLCO as a 
function of age was made using curve estimation. Multiple linear regression was used 
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to model baseline DLCO as a function of the same baseline variables as in the 
longitudinal analysis described below. 
Generalised estimating equations (GEE) was used to analyse change in DLCO as a 
function of baseline variables, including age, sex, height, weight, smoking habits, 
cumulated tobacco exposure in terms of pack years, occupational exposure to dust or 
gas, socioeconomic status represented by educational level, and lastly baseline FEV1. 
We adjusted for baseline DLCO in order to get results based on relative change in DLCO 
instead of absolute change, as one would expect those with higher DLCO values at 
baseline to have larger absolute change in DLCO during follow-up. Continuous 
independent variables were centred around their means. We also decided to investigate 
whether there was an interaction between baseline age and sex, age and smoking 
habits, and sex and smoking habits. Our analysis assumed an exchangeable correlation 
structure. 
Ordinal regression was used to examine whether there was an association between 
change in DLCO and change in dyspnoea, with adjustments for change in weight, age at 
baseline, change in FEV1 change in smoking habits and accumulated pack years of 
cigarettes during the observation time. As in the GEE analysis described above, we 
centred age around the mean value, which was 45 years at the midpoint of the study. 
We also used ordinal regression to investigate if there were baseline predictors for 
baseline dyspnoea score. 
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4. Synopsis of Results 
4.1 Paper I 
DLCO is reduced by approximately 10 % 1-6 hrs after maximal exercise. Mechanisms 
may be interstitial alveolar oedema or reduced pulmonary capillary blood volume, or a 
combination thereof.  
It was hypothesized that thermal stress following exercise contributes to the reduction 
in DLCO, and that skin cooling would attenuate the post-exercise reduction in DLCO. 
Cutaneous vascular conductance (CVC), mean surface temperature (MST), rectal 
temperature and DLCO were measured before and 90 min after maximal incremental 
cycle exercise. Thereafter the subjects were exposed to cold air without eliciting 
shivering one day and another day served as control. The measurements were repeated 
120 min after exercise. Twelve healthy subjects (6 male) aged 20-27 years were 
studied. 
Exercise load, both in terms of peak work load and peak oxygen uptake, were the same 
during the intervention and control settings. DLCO was reduced by 7.1 % (SD=6.3 %, 
p=0.003) and 7.6 % (SD=5.3 %, p < 0.001) 90 and 120 min after exercise in the 
control experiment. It was reduced by 5.6 % (SD=5.5 %, p=0.014) 90 min after 
exercise and remained reduced by 6.1 % (SD=6.1 %, p=0.012) after cooling despite a 
significant reduction in CVC from 0.25 PU ∙ mmHg-1 (SD=0.10) to 0.15 PU ∙ mmHg-1 
(SD=0.11) and in MST from 31.9 (SD=0.6) °C to 27.4 (SD=1.9) °C. Rectal 
temperature was not affected. In the control setting, no variables changed from 90 
minutes post-exercise to final measurements. 
We observed a 10 % reduction in DLCO 90 minutes post-exercise in the men, similarly 
to prior studies. Among the women, observed post-exercise reduction in DLCO was 
only about 5 %. 
We conclude that the post-exercise reduction in DLCO is present when thermal status is 
restored after exercise, and that it is not influenced by further skin surface cooling. 
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4.2 Paper II 
Data on the change in diffusion capacity of the lung for carbon monoxide (DLCO) over 
time is limited. We aimed to examine change in DLCO (∆DLCO) over a 9-year period 
and its predictors.  
A Norwegian community sample comprising 1152 subjects aged 18-72 years was 
examined in 1987/88. Of the 1109 subjects still alive, 830 (75%) were re-examined in 
1996/97. DLCO was measured with the single breath-holding technique. Co-variables 
recorded at baseline included gender, age, height, weight, smoking status, pack years, 
occupational exposure, educational level and spirometry. Generalized estimating 
equations analyses were used to examine relations between ∆DLCO and the co-
variables. 
At baseline mean (standard deviation: SD) DLCO was 10.8 (2.4) and 7.8 (1.6) mmol ∙ 
min-1 ∙ kPa-1 in men and women, respectively. In multiple linear regression, men were 
found to have higher baseline DLCO than women. Higher age, current or ever-smoking, 
and accumulated tobacco smoke exposure were negatively associated with baseline 
DLCO. Positive associations with baseline DLCO were observed for body height, body 
weight and FEV1. Socioeconomic status, in terms of educational level, was also found 
to be associated with baseline DLCO, as those with higher education were found to 
have higher baseline DLCO as compared to those with secondary school in the 
multivariate model. We found no association between occupational exposure to 
airborne agents and baseline DLCO. 
Large variations in ∆DLCO were observed, but with a normal distribution. Mean (SD) 
∆DLCO was -0.24 (1.31) mmol ∙ min-1 ∙ kPa-1. ∆DLCO was negatively related to 
baseline age, DLCO, current smoking and pack years, and positively related to FEV1 
and weight. Gender, occupational exposure and educational level were not related to 
∆DLCO. 
Percent predicted DLCO increased on average 3% during follow-up, while average 
percent predicted FEV1 values were reduced by 3%. 
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Mean VA was significantly reduced from 6.49 L (1.30) at baseline to 6.29 L (1.38) at 
follow-up. No significant change in mean KCO was observed during the study. Women 
and those with higher VA at baseline were found to have a more rapid decline in VA. 
Male sex, higher baseline KCO, higher age, current smoking and pack years were 
associated a more rapid decline in KCO, as was lower body weight and lower 
educational level. 
In a community sample, more rapid decline in DLCO during 9 years of observation 
time was related to higher age, baseline current smoking, more pack years, larger 
weight and lower FEV1. 
4.3 Paper III 
Data on how diffusion capacity of the lung for carbon monoxide (DLCO) influences 
respiratory symptoms is limited. Even more so data on how change in DLCO influences 
change in respiratory symptoms over time. We aimed to examine if there was an 
association between change in DLCO and change in dyspnoea in a community sample 
observed over a period of 9 years. 
A Norwegian community sample comprising 1152 subjects aged 18-73 years was 
examined in 1987 and 1988. Of the 1109 subjects still alive, 830 (75%) were re-
examined in 1996/97. DLCO was measured with the single breath-holding technique. 
Self-reported dyspnoea was recorded using four categories from no dyspnoea to 
dyspnoea at rest. Co-variables recorded included sex, age, height, weight, smoking 
status, pack years, and spirometry. Ordinal regression was used to examine the 
relationship between change in dyspnoea and change in DLCO, with adjustment for 
other co-variables. 
Higher baseline dyspnoea score was associated with lower baseline DLCO, lower 
FEV1, higher age, higher weight. Current smokers and ex-smokers had a significantly 
higher dyspnoea score than never-smokers at baseline. A significant, positive 
correlation between pack years smoked and dyspnoea score at baseline was also found. 
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About 77% of the participants had no change in dyspnoea during the observation time. 
About 6% had a decrease in dyspnoea, and about 17% had an increase. ΔDLCO was -
0.37 mmol · min-1 · kPa-1 for men (95% CI: -0.51 to -0.23) and -0.09 mmol · min-1 · 
kPa-1 for women (95% CI: -0.20 to 0.01). 
We observed an association between reduction in DLCO and increase in dyspnoea 
score in the male part of our sample. In addition, we observed an interaction between 
change in DLCO and baseline age, with a more severe increase in dyspnoea score per 
unit reduction in DLCO with higher age. This interaction was observed in both men and 
women. 
In a community sample with observations over a 9-year period, decline in DLCO was 
associated with an increase in dyspnoea for men, but not for women. The effect 
accelerated with higher age. 
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5. Methodological Discussion 
5.1 Physiological experiment 
5.1.1 Study design 
This study of paper I was designed as a randomised controlled trial, with a variant of 
the crossover design, where all participants went through the experiment with and 
without the intervention, and thus could serve as their own controls. The order of 
which the participants went through the two experiment settings was randomised. 
Participants were recruited from various sports organizations in Bergen, as opposed to 
some prior studies, which have focused on single sport athletes, such as cyclists, 
rowers and runners (21, 25, 63-66). This ensured some heterogeneity in the group, but 
our participants were still a selected sample not representative of the general 
population. One could hypothesise that an even more homogenic group would give 
less variability in measurements and thus higher statistical power. 
Participants were never-smokers with no history of pulmonary, cardiovascular or any 
other severe illness. Before inclusion, they went through a screening process, and were 
found to have normal vital signs and clinical examination findings. 
The randomised controlled trial is considered gold standard when examining a 
response to an intervention. Using a crossover design takes away risk of significant 
differences in the intervention and control arm. In a small study like the present one, 
this is more advantageous than in a larger one with higher statistical power. 
The crossover design requires that the effects of one part of the trial does not carry 
over into the other part of it. Sheel et al. have studied the time course of post-exercise 
reduction in DLCO (20), and found that DLCO values were back to baseline after 24 
hours. In our study, the two parts of the experiment were spaced 5 to 10 days apart, 
and there should be no carry over effect. 
Randomised controlled trials should preferably be blinded when possible, to prevent 
bias in measurements in the intervention and control settings. Ideally, both participants 
and investigators should be blinded to whether they are taking part in the intervention 
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or control setting. With a cold exposure intervention, such as in the present study, 
blinding the participants seems impossible. Blinding of the investigators could 
however have been done. The cold exposure induced a significant reduction in surface 
temperature, which probably would have been detectable upon touch when placing the 
skin probes post intervention. Gloves worn by the investigator could maybe have 
prevented that. 
If the hypothesis had been confirmed, one might argue that the lack of blinded 
observers and participants could have worked to explain the result. However, as the 
hypothesis was not confirmed, we think that the impact on the results of unblinded 
observers and participants was minor. 
 
5.1.2 Pulmonary function testing 
Single breath measurement of DLCO is the most widely used measurement of 
pulmonary gas exchange and was performed to standards recommended by the ATS 
and ERS. Observed values should therefore be comparable to those found in prior 
studies. 
Measurements of DM and VC by performing DLCO measurements twice with different 
partial pressures of oxygen could have given some clues to the mechanisms behind the 
observed DLCO-values in this study. Unfortunately, we did not have a setup with the 
additional test gas available. However, with the observed results of no significant 
change in DLCO after vasoconstriction, observations of DM and VC would not have 
had any value.  
5.1.3 Exercise protocol 
Several different modalities of exercise have been used in prior studies, including 
marathon running, triathlon, row ergometers and arm cranking (21, 23, 63, 67, 68). An 
incremental work load bike ergometer was used in the present study, and it was 
designed to bring participants to exhaustion in 15-20 minutes. Similar exercise 
protocols have also been used in several other studies on post exercise reduction in 
DLCO (69, 70). 
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The exercise protocol induced a reduction in DLCO of similar magnitude as has been 
observed by others, at least for the male part of the sample. In this regard, it must be 
considered to have been adequate. For the sake of comparability, we could have used 
exactly the same protocol as some of the prior studies, as they are well described in the 
published articles. 
5.1.4 Measurement of skin perfusion 
Direct measurement of skin blood volume in live specimens is not available. We chose 
to use laser Doppler flowmetry (LDF) due to availability. This method was developed 
to measure blood flow and not volume, but flow is a product of the cross-sectional 
area of the vessel and the blood velocity. Perfusion unit values acquired through LDF 
is a product of two factors, the amount laser light reflected from red blood cells, 
concentration of moving blood cells (CMBC), and the velocity of the red blood cells, 
represented by the frequency shift in reflected light. 
The number of blood cells in a given sample of skin, is proportional to the blood 
volume in the sample, as long as the erythrocyte volume fraction (EVF) is constant. 
We did not draw blood samples to measure EVF, but subjects drank 500mL of water 
post exercise, to compensate for fluid loss. EVF measurements parallel to flowmetry 
would have added to the validity of the measurements. 
LDF shows a large variability, with coefficients of variance with repeated 
measurements estimated to 20%-58% (71-74). However, arterial blood pressure affects 
blood flow, and the above variance estimates are for unadjusted perfusion units. We 
chose to use LDF and mean arterial pressure to calculate cutaneous vascular 
conductance CVC in order to be certain that an observed change in blood flow was not 
only due to change in blood pressure, and at the same time reduce the variability 
somewhat. Conductance is regulated through vasodilation and -constriction, which 
correlates with the volume of blood that can be accommodated in the vessel. It can be 
thus used as an indirect measurement of blood volume. This is the method also used in 
several prior studies on skin hemodynamics in relation to exercise (75-77). 
LDF only samples about 1mm3 per probe. Using five probes placed on different 
regions of the skin, alleviates some of the problems with this small sampling volume, 
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but we are still measuring only a very small fraction of the whole skin tissue. 
Additionally, it was not possible to wear the probes during the entire experiment. We 
drew the outline around each probe at baseline, but the accuracy of that method was 
not enough to reproduce probe placement within 1mm2, and therefore we were not 
measuring the exact same skin tissue sample at each point. 
Skin photoplethysmography is a method that also uses reflected light, and can be used 
to measure changes in blood volume (78). Using light of different wavelength, it can 
measure changes deeper into the skin (79), and it can also be used in conjunction with 
LDF (80). Unfortunately, this method was not available to us. 
Although LDF has its limitations, using it to calculate cutaneous vascular conductance 
is well known, as it has been used in several studies on skin hemodynamics. 
5.1.5 Cold exposure intervention 
We utilised exposure to ambient outside temperature to reduce skin temperature and 
induce cutaneous vasoconstriction. The experiment was performed during the winter 
months, in the western part of Norway, and the air temperature ranged from 3°C to 
9°C. The exposure was terminated at the first observed involuntary muscle twitch, 
which took place after 8 to 15 minutes in our sample. 
The skin cooling protocol could have been standardised better using a climate chamber 
or liquid cooling garment, but neither was available to us. 
Cutaneous vasoconstriction was the goal of the cold exposure. Vasoconstriction can be 
induced both by reduced skin temperature (81) and reduced core temperature with 
normal skin temperature (82) After heat retention by means of vasoconstriction, 
shivering is the next autonomic response to prevent further body temperature 
reduction. Shivering starts at a core temperature threshold about 1°C lower than that of 
vasoconstriction (82). Circulating norepinephrine becomes dramatically elevated even 
by a small reduction in core temperature, with dramatic effects on systemic 
hemodynamics (83). By terminating the exposure when we observed the first 
uncontrolled muscle twitch, we could be fairly certain that vasoconstriction had 
occurred, but without a significant reduction in core temperature. Our results showed a 
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significant reduction in CVC, without any change in heart rate, blood pressure or core 
temperature, suggesting that cutaneous vasoconstriction was achieved without any 
systemic sympathetic response. 
 
5.1.6 Statistical methods 
Student’s t-test is the most widely used statistical method for comparing mean values. 
We utilised the variation of this test for analysing paired samples. With testing of 
multiple pairs, the risk of type I errors increases. We therefore used Bonferroni 
corrections to adjust for that. 
A regression analysis might have been used to model change in post-exercise to post-
intervention DLCO as a function of change in cutaneous vascular conductance or using 
the underlying measurements of LDF and adjusting for blood pressure, but just 
comparing the means seemed the most intuitive to us. 
5.1.7 Validity of the study 
We used thoroughly tested and widely used methods for measurement of DLCO, and 
observed results similar to others, and are fairly certain that our observations represent 
pulmonary gas exchange. 
As discussed above, there is no plausible method for direct measurement of skin blood 
volume in live specimens, and we cannot be completely certain that we actually 
measured changes in blood volume in the skin. We did however utilise both 
flowmetry, conductance calculations and skin temperature measurements, which are 
all associated with vasodilation and vasoconstriction, which results in changes in skin 
blood volume. 
5.2 Hordaland County Cohort Study 
5.2.1 Study design 
This was a prospective cohort study of a general population sample. It is a design well 
suited for modelling normal trajectories in lung function. It has a sample size and 
observation time which are comparable to prior studies (48, 49). The response rates 
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were high both at baseline and follow-up. A 9-year follow-up is adequate to detect 
changes in DLCO in healthy individuals without requiring an even larger sample 
population.  
Additional observation points would have strengthened the study and made modelling 
more precise and less vulnerable to regression towards the mean. An even longer 
observation time would also have added to the study. However, a longer observation 
time would be a trade off versus increased loss to follow-up and survival bias  
Stratified sampling made analyses possible on subsamples of the study population 
which would probably have been too low in numbers with ordinary randomised 
sampling, as our analyses of occupational exposure. Stratification in this way does 
however make the study population less representative of the general population. 
5.2.2 Data collection 
Pulmonary function testing was performed in accordance with guidelines, with robust 
routines for calibration and monitoring with biological controls. Using the exact same 
apparatus for pulmonary function testing at both baseline and follow-up is also a 
strength of this study. Furthermore, we had measurements of haemoglobin and 
carboxyhaemoglobin in blood, which could be confounders when studying changes in 
DLCO. 
A significant proportion of the participants were not able to achieve an IVC/FVC-ratio 
of at least 0.85. Not meeting this criterium could lead to an underestimation of VA, and 
consequently DLCO. However, after performing further analyses of the dataset, we 
found that including also those with a ratio between 0.7 and 0.85 did not alter our 
results significantly and chose to include them in the final results. 
Data on dyspnoea was self-reported and thus dependent on variability in the 
perception of dyspnoea. It is not an objectively quantifiable symptom. Dyspnoea score 
was an ordinal variable with five possible values, which gives a somewhat low 
resolution in the collected data but makes reporting easier for the participants than 
choosing from a large number of possible values. We might have exposed the 
participants to a physical challenge test, such as a ramp protocol on a treadmill, and 
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asked them to rate their level of dyspnoea on a visual analogue scale at specified time 
points, to get more resolution to the dyspnoea score. However, this would have been 
very expensive with such a large sample.  
5.2.3 Statistical methods 
Generalised estimating equations is a robust method for analysing data sets from 
epidemiological surveys with repeated measurements of the outcome variable. Prior 
studies (48, 49) have utilised random effects models, which also is used for analysis of 
longitudinal, epidemiological data. The two methods differ in how they are interpreted 
but are both valid methods in this setting. 
Longitudinal data with only two data points will be susceptible to regression towards 
the mean. We adjusted for baseline DLCO, which compensates for that to a degree. 
Change in dyspnoea score, which was the outcome variable in paper III, is an ordinal 
variable, with possible values from -4 to 4. This made ordinal regression the obvious 
method to analyse the data. 
5.2.4 Validity of the study 
This is a relatively large epidemiological survey with a 9-year follow-up and high 
response rates. The main weaknesses are the ratio of participants who were not able to 
fulfil the criteria for a technically acceptable DLCO-measurement, and that the survey 
only has two points of observation. 
External validity 
External validity is a measure of how well the sample population represents the 
reference population, and thus to which degree the observed results in the sample can 
be generalized. The sample included in the Hordaland County Cohort Study has been 
found to representative of the population it was sampled from with regards to age, 
gender and smoking habits (60, 84, 85). 
Internal validity 
Internal validity is a measure of how well the results and conclusions in a study 
actually represent phenomena in the study population. The validity of pulmonary 
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function testing procedures and statistical methods have been discussed above. 
Considerations regarding bias and confounding does warrant further discussion. 
Selection bias occurs when those who respond to an invitation to take part in a survey, 
are significantly different from the non-responders. Selection bias has been assessed 
for the Hordaland County Cohort Study before (86, 87), and it was found that there 
were more smokers among the non-responders. 
In a longitudinal survey, systematic differences between those who were lost to 
follow-up as compared to those who stayed in the survey, will lead to attrition bias. In 
the current study, we observed that those who were lost to follow-up were 
significantly older and had significantly lower lung function than those who remained 
in the study. One could hypothesise that this would be due to higher morbidity and 
mortality in the former group. If those who were lost to follow-up had remained in the 
study, we would probably have observed an even stronger association between 
accelerated decline in DLCO with higher age, and a stronger association between 
smoking and rate of decline in DLCO. 
Information bias occurs when there is a skewness in how different subgroups on the 
sample population report data. In the present study, smoking habits, occupational 
exposure and level of dyspnoea were probably the data most susceptible to 
information bias. 
Social conventions may cause smokers to underreport their smoking habits, which 
could cause the observed association between smoking and change in DLCO to be 
weaker than it actually was. Additionally, smokers have been observed to also 
underreport respiratory symptoms (88), which could lead to an association between 
change in smoking habits and change in dyspnoea not being detected. 
Recall bias could cause underreporting of occupational exposure to dust or gas due to 
the fact that not everybody would recall such exposure. It could also lead to skewness 
in reporting, as those who get respiratory symptoms or disease, might have had better 
recollection of occupational exposure, than those who did not have any respiratory 
problems. 
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Differences in physiology and psychology may cause men and women to perceive 
dyspnoea differently, contributing to the fact that an association between change in 
DLCO and change in dyspnoea among women was not observed in the current study 
(89). Social conventions causing a higher threshold for men to report symptoms 
associated with lower levels of fitness and work capacity have also been discussed 
(90). Our findings of a gender difference are similar to observations from cross-
sectional studies on both DLCO (35, 90) and FEV1 (54). 
Confounding takes place when one finds an association between an independent and 
dependent variable, but the reality is that there is a third variable, which is associated 
with the independent variable, which is the cause of the observed association. One 
could argue that the observed association between smoking and rate of decline in 
DLCO, was due to smoking causing the airways to have less conductance, which could 
lead to air trapping, and not the gas exchange over the alveolocapillary membrane 
itself. In our analyses, we adjusted for FEV1 to compensate for this possible 
confounder. Additionally, men tend to have a taller and heavier body stature but 
adding height and weight to our analyses adjusted for that. Other possible confounders 
we have taken account for are: Occupational exposure and smoking, occupational 
exposure and socioeconomic status, socioeconomic status and smoking, sex and 
smoking habits, weight gain which could possibly cause an increase in dyspnoea. 
By using standardised data collection and utilising validated methods, as well as 
including potential confounders in our multivariate analyses, we can be fairly certain 
our conclusions are valid, which is in line with the conclusion of previous discussions 
by Aanerud regarding the validity of this survey (62). 
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6. Discussion of the Results 
6.1 Physiological experiment 
6.1.1 A negative study 
We observed a reduction in DLCO of about 10% 90 minutes after a bike ergometer 
ramp protocol until exhaustion in the men in this study. This finding is in line with 
prior studies (20). A post-exercise reduction of 5% was observed in the women. 
Mean surface temperature and cutaneous vascular conductance were not significantly 
different from baseline 90 minutes post-exercise. This observation in itself suggests 
that changes in skin hemodynamics does not play a major role in the reduction of 
intrathoracic blood volume after exercise. 
Skin cooling by exposure to cold air significantly reduced mean surface temperature 
and cutaneous vascular conductance. Even though this suggests cutaneous 
vasoconstriction had occurred, no further change in DLCO was observed. Heart rate, 
blood pressure and core temperature were not affected by skin cooling, giving no 
evidence of a systemic sympathetic response.  
6.1.2 First study on women 
A reduction of about 5% 90 minutes after exercise was observed in the women in this 
study. No prior studies on post-exercise reduction in DLCO in women have been 
published to our knowledge. 
There are gender differences in post-exercise hemodynamics among endurance trained 
men and women (91, 92). Oestrogen and progesterone have been shown to be 
vasoactive (93). Lynn et al. did not find a pattern of variation in post-exercise 
hemodynamics through the menstrual cycle, although resting hemodynamics was 
observed to vary significantly (94). It is currently not known whether this affects 
intrathoracic blood volume to an extent which influences DLCO. 
6.1.3 False negative? 
A false negative conclusion occurs when one makes the error of rejecting a hypothesis 
which is in fact true. This can be due to poor statistical power caused by high 
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variability, insufficient sample size, or a combination of the two. It can also be due to 
application of inadequate methods of low validity to the study. 
Sheel et al. examined the time course of post-exercise reduction in DLCO, and found an 
ongoing reduction until 6 hours, after which they had no observation point until 24 
hours post-exercise. Our measurements took place 90 minutes and 120 minutes post-
exercise, and one could hypothesise that skin cooling attenuated an ongoing reduction. 
We did however not observe any further reduction in DLCO from 90 to 120 minutes 
post-exercise in the control setting. Additionally, skin hemodynamics were not 
different from baseline after exercise, as mentioned above. With all observations 
pointing in the same direction, we assume the risk of this being a false negative study 
to be low. 
6.1.4 Blood redistribution elsewhere? 
Post-exercise hemodynamics is characterised by increased systemic vascular 
conductance and reduced arterial blood pressure (95). A reduction in intrathoracic 
blood volume has been observed (29), and it has been hypothesised that it is caused by 
redistribution to organs recovering after the physical effort. An increase in blood 
volume in the muscles in the thigh was observed by Hanel et al. (29), but not to an 
amount which could explain the entire reduction in DLCO. The gut delivers nutrients 
needed in the recovery phase after exercise, and pooling of blood in the gut could play 
a role in the post-exercise depletion of intrathoracic blood volume. A diffuse pooling 
of blood in the peripheral venous system, not large enough to be easily detected at 
each individual site, could also be the underlying mechanism of redistribution of blood 
from the central organs. 
6.2 Hordaland County Cohort Study 
6.2.1 Decline in DLCO accelerates with higher age 
We observed an average yearly change in DLCO of -0.025 mmol ∙ min-1 ∙ kPa-1, with an 
accelerated decline with higher age in our multivariate model. These findings are 
comparable to prior studies (48, 49). We found that age squared gave the best estimate 
for change in DLCO as a function of age, which supports the results from the 
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multivariate analysis. The association between age and the rate of decline in DLCO was 
independent of the other baseline variables included in the multivariate model. 
Age-related reduction in alveolar ventilation, impaired cardiac function, increased 
emphysema and elevated pulmonary blood pressure might be explanations of the 
accelerated decline in DLCO with higher age (96). 
6.2.2 Smoking associated with accelerated decline in DLCO 
Smoking and accumulated tobacco exposure were predictors of both lower baseline 
DLCO and a more rapid decline during the 9-year follow-up in the present study. Prior 
studies have also found smoking to be associated with lower baseline DLCO (48, 49). 
Others have found an association between smoking and rate of decline in DLCO in 
firefighters (41) and a sample of 84 middle-aged men (42), but we are the first to 
observe an association between smoking and decline in DLCO in a general population 
sample. By including cumulative tobacco smoke exposure measured by pack years, we 
found a dose-response relationship between smoking and rate of decline in DLCO. 
DLCO may be reduced due to airflow limitation caused by smoking. However, our 
observed associations between smoking status and change in DLCO and pack years and 
DLCO were independent of change in FEV1. 
Smoking is associated with amount of emphysema (97), which reduces the area of the 
alveolocapillary membrane, and thus DLCO. An association between level of 
emphysema and level of DLCO, after adjusting for FEV1, has also been observed (98). 
Together with our data, this may suggest that smoking causes a more rapid decline in 
DLCO at least partly due to development of emphysema. 
Smokers have a higher risk of developing anaemia than non-smokers (99), which may 
lead to lower DLCO-values. Smokers also have higher levels of carboxyhaemoglobin in 
blood, which further reduces observed DLCO-values (14). Our findings did however 
persist after adjusting DLCO-values for haemoglobin-concentrations and fraction of 
carboxyhaemoglobin in blood. 
Of the other comparable studies, the Po-delta survey had a lower response rate than the 
current study. Smokers have been found to be lost to follow-up more often than non-
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smokers (87). The Tucson survey had fewer participants and did not include any 
participants over the age of 59 at baseline. This can explain why these two studies did 
not find an association between smoking and the rate of decline in DLCO. 
6.2.3 Comparison to cross-sectional surveys 
We observed a significant increase in percent of predicted DLCO of 3% using European 
reference equations (53), while absolute values were reduced. This suggests that the 
equations, which are based on cross-sectional data, may overestimate the age-
coefficient in their model. The discrepancy may be due to a cohort-effect, confounders 
such as smoking and occupational exposure, or regression towards the mean in the 
longitudinal data. We adjusted for baseline DLCO to compensate for the latter. 
6.2.4 Dyspnoea-DLCO-association 
An association between DLCO and respiratory symptoms has been observed in cross-
sectional studies before (35, 90). This is however the first study where an association 
between change in dyspnoea and change in DLCO has been found. The association was 
only found in the male participants. The same results were found for KCO, but there 
was not observed any association between change in VA and change in dyspnoea. 
As for the association between smoking and rate of decline in DLCO discussed above, 
level of emphysema may be the underlying link between change in DLCO and change 
in dyspnoea, as Grydeland et al. have observed both an association between amount of 
emphysema and respiratory symptoms (100) and amount of emphysema and level of 
DLCO (98). Reduced DLCO may also have extrapulmonary causes, such as cardiac 
insufficiency, which may cause an increase in dyspnoea. Fatigue due to systemic 
inflammation, which has been found to be associated with impaired gas exchange, 
may also contribute to our findings. 
6.2.5 DLCO has stronger impact on dyspnoea with higher age 
An interaction between age and change in DLCO was observed in both the men and 
women in this study, suggesting a larger increase in dyspnoea per unit of decline in 
DLCO with higher age. One hypothesis to the cause of this, could be reduced reserve 
capacity in the cardiovascular and respiratory systems with higher age, making older 
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people for instance less able to compensate for reduced gas exchange due to 
impairments in the lung by increasing cardiac output. 
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7. Summary 
We have confirmed the finding of others of a post-exercise reduction in DLCO. Change 
in skin hemodynamics related to thermoregulation does not seem to be a contributing 
factor to the reduction in intrathoracic blood volume which others have observed. 
We are the first to study post-exercise reduction in DLCO in women and found a 
significantly lower reduction in DLCO for the women compared to the men. 
Our findings confirm the observations of others of an accelerated decline in DLCO with 
higher age. We are the first to find an association between smoking and decline in 
DLCO in a longitudinal survey of a general population sample. The association showed 
a dose-response-relationship between accumulated tobacco smoke exposure and rate 
of decline in DLCO. 
Finally, we found an association between decline in DLCO and increased dyspnoea 
score among the men in our study, but no such association among the women. A 
significant interaction between change in DLCO and baseline age was present, with a 
more severe increase in dyspnoea per unit of change in DLCO with higher age. 
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8. Conclusions 
1. Redistribution of blood from the intrathoracic space to the skin does not seem 
to be a contributing mechanism of post-exercise reduction in DLCO. 
2. In a general population sample of 830 subjects and a follow-up of 9 years, we 
observed a mean change in DLCO of -0.025 mmol ∙ min-1 ∙ kPa-1 ∙ year-1. Higher 
age, smoking, lower FEV1 and lower weight were associated with a more rapid 
decline in DLCO. 
3. Decline in DLCO was associated with increasing dyspnoea in the male part of 
our sample. No such association was observed among the women. An 
interaction between change in DLCO and age at baseline was observed, with a 
more severe increase in dyspnoea per unit of decline in DLCO with higher age. 
The interaction was significant for both men and women. 
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9. Perspectives 
A better understanding of the variability of DLCO-measurements, will make us able to 
take precautions to reduce that variability, and give clinicians in pulmonology a more 
reliable tool to diagnose and monitor disease. This may lead to detection of some 
pulmonary diseases at an earlier stage and more accurate staging of severity, with 
possibilities of early intervention and improved prognosis. In addition, researchers will 
gain a higher statistical power in studies involving DLCO-measurements, and thus 
requiring less participants and resources to perform analyses with robust results. 
Even though Hanel et al. were able to describe and quantify depletion of the central 
blood volume, and an increase in the blood volume in the muscles of the thigh (29), 
the mechanisms of post-exercise are not fully understood. Modern imaging techniques, 
such as SPECT, may give deeper insight into post-exercise redistribution of blood if 
they are applied to this field of research. 
Differences between post-exercise systemic hemodynamics have been observed by 
others (94), but we are the first to observe an association between sex and magnitude 
of post-exercise reduction in DLCO. Further studies which also take menstrual cycle 
and vasoactive sex hormones into account are needed to confirm our findings and shed 
light on possible mechanisms. 
Decline in DLCO accelerates with higher age, and a better understanding of the ageing 
of the pulmonary and cardiovascular system is needed to understand why. With the 
coming age wave in Europe and Northern America, we will see an increasing 
proportion of the population in the higher age groups. A better understanding of the 
lung health in the elderly, might give us measures to provide better health and quality 
of life for this group, and give more life to the years. 
A better understanding of the lung health in the elderly includes a characterisation of 
the trajectories of DLCO in the elderly and what genetic and environmental risk factors 
that influences these trajectories. 
As stated above, predicted values for DLCO using reference equations based on cross-
sectional surveys, seem to overestimate the age coefficient when compared to 
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longitudinal data, which may lead to erroneous conclusions when diagnosing or 
monitoring patients in clinical settings. Our data suggest that the existing reference 
equations should be reconsidered, which they actually recently have been, using novel 
approaches and statistical methods (101).  
Smoking is a well-known risk factor for a host of diseases and health issues. The 
majority of research on smoking and lung health has been focused on lung cancer, and 
impact on airway obstruction and lung function in terms of FEV1. Less is known about 
smoking and its effect on pulmonary gas exchange, beyond that related to airway 
obstruction. Further longitudinal studies on smoking and DLCO, coupled with modern 
methods for describing pulmonary structure, biochemistry and cell biology may give 
us an even better understanding of the decremental impact of smoking on lung health, 
and provide more background information for policy makers. 
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Summary
Pulmonary diffusion capacity for carbon monoxide (DLCO) is reduced by
approximately 10% 1–6 h after maximal exercise. The mechanisms may be
interstitial alveolar oedema and reduced pulmonary capillary blood volume. It was
hypothesized that thermal stress following exercise contributes to the reduction in
DLCO, and that skin cooling would attenuate the postexercise reduction in DLCO.
Cutaneous vascular conductance (CVC), mean surface temperature (MST), rectal
temperature and DLCO were measured before and 90 min after maximal incremental
cycle exercise. Thereafter, the subjects were exposed to cold air without eliciting
shivering one day and another day served as control. The measurements were
repeated 120 min after exercise. Twelve healthy subjects (six male) aged 20–27
years were studied. DLCO was reduced by 7Æ1% (SD = 6Æ3%, P = 0Æ003) and 7Æ6%
(SD = 5Æ3%, P<0Æ001) 90 and 120 min after exercise in the control experiment. It
was reduced by 5Æ6% (SD = 5Æ5%, P = 0Æ014) 90 min after exercise and remained
reduced by 6Æ1% (SD = 6Æ1%, P = 0Æ012) after cooling despite a significant
reduction in CVC and in MST from 31Æ9 (SD = 0Æ6)C to 27Æ4 (SD = 1Æ9)C. We
conclude that the postexercise reduction in DLCO is present when thermal status is
restored after exercise, and that it is not influenced by further skin surface cooling.
Introduction
Diffusion capacity of the lung for carbon monoxide (DLCO) is
reduced by approximately 10% 1–6 h after maximal exercise in
men, with complete recovery within 24 h (Sheel et al., 1998).
The reduction in DLCO in this late recovery phase after exercise is
lower with submaximal exercise (Hanel et al., 1993), and has
been demonstrated after running, cycling and rowing (Rasmus-
sen et al., 1986; Hanel et al., 1997; McKenzie et al., 2005). There
is no significant difference in the postexercise reduction in DLCO
in untrained, moderately trained and highly trained individuals
(Sheel et al., 1998). Variability is of major concern with
measurements of DLCO in clinical practice and epidemiological
studies (Welle et al., 1999; Jensen et al., 2007), and some of this
variability could be attributed to the physical activity level
during the last 24 h before the measurement.
Subclinical pulmonary oedema owing to elevated pulmonary
capillary pressure was first suspected to be the major cause of the
reduction in DLCO (Rasmussen et al., 1986; Manier et al., 1991),
as it would increase the thickness of the blood–gas barrier. This
has been observed in elite marathon runners, cyclists and
triathletes (Caillaud et al., 1995; Hopkins et al., 1998; McKenzie
et al., 2005), but not in less-trained subjects (Gallagher et al.,
1988) and not after moderate-intensity exercise (Hodges et al.,
2007). The functional significance of the reduction in DLCO is
minimal. Exercise can be continued to the same peak oxygen
uptake 4 h after a preceding maximal exercise test despite a
lower pre-exercise DLCO (Hanel et al., 1994).
Partition of DLCO into the membrane and blood components
indicates a reduced pulmonary capillary blood volume as the
major cause for the reduction in DLCO (McKenzie et al., 2005),
and a reduced intrathoracic blood volume has been demonstrated
by transthoracic bioimpedance measurements and radioactively
labelled erythrocytes (Hanel et al., 1997). There is a general
reduction in systemic vascular resistance after exercise (Halliwill,
2001), and increased blood flow and volume in skeletal muscle
recovering after exercise (Hanel et al., 1997).
The skin blood volume in thermoneutral conditions is
estimated to be about 2% of the total blood volume (Pang,
2001), and indirect evidence suggests 500–600 ml of blood
may be pooled in the cutaneous circulation with whole body
heating (Rowell, 1986). Skin blood flow and volume is
increased during exercise, and in the recovery phase owing to
the thermal stress of exercise could then contribute to the
redistribution of blood volume away from the intrathoracic
circulation after exercise. Thermal status influences the mea-
surement of DLCO (Cotes et al., 2006), but it is not known
whether elevated body temperature and cutaneous vasodilation
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contributes to the postexercise reduction in DLCO. If so, it would
be expected that skin surface temperature increased in the late
recovery phase after exercise, and that skin surface cooling
might attenuate the reduction in DLCO.
Methods
Twelve healthy well-trained subjects aged 20–27 years partic-
ipated in the study (six men) and all were never-smokers. They
exercised an average 8 h a week (range 2–13 h). Their
anthropometric characteristics, dynamic lung volumes and peak
oxygen uptake by cycle ergometry are given in Table 1. The
study was approved by the regional ethics review committee
and all subjects gave written informed consent.
Protocol
Each subject performed progressive exercise until exhaustion on
a cycle ergometer on 2 days 5–10 days apart, and they had not
involved in exercise during the last 24 h. Before exercise,
baseline measurements of skin perfusion, skin temperature,
rectal temperature, arterial blood pressure, heart rate and DLCO
were carried out and repeated 90 min after the end of exercise.
This recovery was indoors at a room temperature of 21–22C on
both days. The subjects were requested to drink 500 ml water to
compensate for fluid loss during this period. Thereafter, the
subjects either remained indoors at the same temperature for
another 30 min as control, or they were subjected to skin
surface cooling outdoor at ambient temperature of 3–9C
wearing shorts and t-shirts. Cooling was continued until the first
uncontrolled muscle twitch appeared, but without eliciting
shivering. The duration of the cooling procedure ranged from
8 to 15 min. All measurements were repeated after the
control and cooling exposure, which were in random order
on the 2 days. All measurements were done in the same order
each time.
Cycle ergometry
The exercise protocol included a 5-min warm-up period with a
workload of 70 W for men and 50 W for women. After this, the
workload was increased by 20 or 15 W per min for women,
and oxygen uptake was recorded by a Sensormedics Vmax
Spectra 229 (Viasys Healthcare Inc., Conshohocken, PA, USA)
using a mouthpiece and nose clip.
Lung function measurements
Measurements of dynamic lung volumes and DLCO were
performed in accordance with the American Thoracic Society
and European Respiratory Society guidelines (MacIntyre et al.,
2005; Miller et al., 2005) on a Morgan Benchmark (PK Morgan
Ltd, Kent, UK) lung function testing apparatus. All measure-
ments were done with the subjects seated wearing a nose clip.
Measurement of DLCO was done with the single-breath-holding
method, with helium added to the test gas to calculate effective
alveolar volume (VA). The subjects first exhaled to residual
volume, then inhaled the test gas to total lung capacity and held
their breath for 10 s before exhalation. Upon exhalation, the
first 1 l of gas was disregarded, while the next 700 ml, assumed
to be alveolar gas was analysed for CO and He concentrations.
The mean of two technically satisfactory tests, with values no
more than 10% apart, was recorded. Diffusion coefficient of the
lung for CO (KCO) was calculated as DLCO · VA)1.
Surface temperature and cutaneous perfusion
Cutaneous perfusion and surface temperature were measured by
means of laser Doppler flowmetry and integrated thermostatic
probes. The PeriFlux System 5000 equipped with five PF 5010
laser Doppler units with wavelength 780 nm, and four PF 5020
heating units (Perimed AB, Stockholm, Sweden) was used. The
angled thermostatic laser Doppler probes (Perimed AB) had a
fibre separation of 0Æ25 mm. Given the aforementioned wave-
length and fibre separation, the laser light is conducted by
optical fibres to the skin where it penetrates 0Æ5–1Æ0 mm and is
partly reflected. When the light is backscattered by moving
erythrocytes, there will be a frequency shift which is propor-
tional to the velocity of moving erythrocytes. The amount of
backscattered light is dependent on the number of erythrocytes.
Based on this, skin perfusion can be calculated, and is expressed
in arbitrary perfusion units (PU) (Bonner, 1981; Gush et al.,
1984).
Surface temperatures were recorded on the lateral part of the
right calf, over the medial head of the right quadriceps, on the
lateral part of the right biceps brachii and in the right
mid-clavicular line, 2Æ5 cm below the clavicula. To calculate
mean surface temperature (MST), temperatures from the four
locations were weighted according to Ramanathan (1964).
Cutaneous perfusion was measured by the same probes and in
the same locations as for measurements of surface temperature.
An additional probe was placed 2 cm below the right processus
zygomaticus. For recording of surface temperature and perfu-
sion, the subjects rested supine while measurements were
performed for 5 min. The first 4 min were disregarded, and the
mean over the last minute was used for analysis. The mean skin
Table 1 Subject characteristics.
Male (n = 6) Female (n = 6)
Age 24 (1) 23 (3)
Height (m) 1Æ79 (0Æ05) 1Æ72 (0Æ03)
Body mass (kg) 72Æ5 (6Æ3) 67Æ2 (4Æ1)
BMI (kgÆm)2) 22Æ7 (2Æ0) 22Æ8 (1Æ3)
FVC (% pred.) 107 (9) 105 (15)
FEV1 (% pred.) 100 (9) 101 (16)
Exercise (hÆweek)1) 8 (4) 8 (3)
VO2peak (mlÆkg
)1Æmin)1) 50Æ3 (4Æ6) 43Æ4 (5Æ5)
Values are mean (SD). BMI, body mass index; FVC, forced vital capacity;
FEV1, forced expiratory volume in 1 s; VO2peak, peak oxygen uptake.
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perfusion (MSP) was calculated using mean values over the last
minute from all five probes without any weighting.
Rectal temperature was measured immediately before the
skin temperature and perfusion measurements, and blood
pressure was measured by sphygmomanometry immediately
after the cutaneous perfusion and temperature recordings, with
the subjects in the supine position. The mean blood pressure
was calculated as diastolic pressure plus one-third of pulse
pressure, and mean cutaneous vascular conductance (CVC) was
calculated as mean skin perfusion divided by mean blood
pressure.
Statistics
All data are given as mean (standard deviation). Differences
from baseline and differences between postexercise and post-
intervention measurements were tested using paired Students
t-test. The Bonferroni method was used to correct for multiple
comparisons. A P-value less than 0Æ05 was considered signifi-
cant.
Results
The subjects exercised to the same peak work load and oxygen
uptake both days. The peak oxygen uptake was 3Æ01
(0Æ54) l min)1 and 3Æ16 (0Æ64) l min)1. The duration of the
exercise bout was 15–20 min in both men and women,
including the 5-min warm-up period. There were no differences
in the baseline and 90-min postexercise MST and mean CVC
(Table 2 and Fig. 1). There was a minimal reduction in rectal
temperature. The mean arterial pressure did not differ from
baseline, but the heart rate was reduced 90-min postexercise.
There was a decrease in MST from 31Æ9 (0Æ6)C to
27Æ4 (1Æ9)C after skin cooling (P<0Æ001), but no change from
90- to 120-min postexercise in the control experiment. There
was no further reduction in the rectal temperature. CVC showed
the same pattern of change as MST, with a drop from 0Æ25
(0Æ10) to 0Æ15 (0Æ11) PUÆmmHg)1 after skin cooling
(P = 0Æ001). During the control, CVC did not change. Blood
pressure did not change, but heart rate remained slightly
reduced compared with baseline measurements.
The DLCO was reduced 90-min postexercise in both exper-
iment and control, by 5Æ6 (5Æ5)% (P = 0Æ014) and 7Æ1 (6Æ3)%
(P = 0Æ003), respectively. After skin cooling, DLCO remained
reduced by 6Æ1 (6Æ1)%, and after the control DLCO was still
reduced by 7Æ6 (5Æ3)% (Fig. 1).
The 90-min postexercise reduction in DLCO was 7Æ6 (6Æ7)%
and 10Æ7 (4Æ0)% on the days for experiment and control in men,
and 3Æ6 (3Æ6)% and 3Æ5 (6Æ3)% for women. There were no
changes in VA, and the pattern of change in KCO was the same as
for DLCO.
Discussion
The men in this study had a mean postexercise reduction in
DLCO of about 10% after symptom-limited progressive exercise
on a cycle ergometer, whereas the women had a reduction of
less than 5%. At least in the men, the reduction in DLCO in this
study was comparable with other studies of young moderately
and well-trained men (Sheel et al., 1998). Whether there are
Table 2 Diffusion capacity of the lung for
carbon monoxide (DLCO), temperature and





Experiment with skin cooling
DLCO (mmolÆmin
)1ÆkPa)1) 10Æ6 (2Æ4) 9Æ9 (1Æ8)* 9Æ9 (1Æ9)*
KCO (mmolÆmin
)1ÆkPa)1 l)1) 1Æ8 (0Æ2) 1Æ7 (0Æ2)* 1Æ7 (0Æ2)*
Rectal temperature (C) 37Æ3 (0Æ4) 36Æ9 (0Æ5)* 37Æ0 (0Æ6)*
MAP (mm Hg) 85Æ9 (3Æ9) 85Æ4 (5Æ5) 87Æ6 (6Æ7)
MST (C) 31Æ5 (0Æ3) 31Æ9 (0Æ6)* 27Æ4 (1Æ9)*
Mean skin perfusion (PU) 18Æ0 (4Æ8) 20Æ9 (7Æ0) 12Æ9 (7Æ8)*
Conductance (PUÆmmHg)1) 0Æ21 (0Æ06) 0Æ25 (0Æ10) 0Æ15 (0Æ11)
Heart rate (BPM) 64 (11) 58 (12)* 54 (7)*
Control
DLCO (mmolÆmin
)1ÆkPa)1) 10Æ6 (2Æ6) 9Æ8 (2Æ0)* 9Æ8 (2Æ1)*
KCO (mmolÆmin
)1ÆkPa)1Æl)1) 1Æ8 (0Æ3) 1Æ7 (0Æ3)* 1Æ7 (0Æ3)*
Rectal temperature (C) 37Æ1 (0Æ2) 36Æ9 (0Æ2)* 36Æ9 (0Æ2)*
MAP (mm Hg) 87Æ8 (6Æ0) 84Æ3 (5Æ8)* 85Æ6 (5Æ1)
MST (C) 32Æ0 (0Æ6) 32Æ4 (1Æ1)* 32Æ6 (1Æ0)*
Mean skin perfusion (PU) 21Æ5 (7Æ8) 22Æ2 (7Æ6) 25Æ5 (12Æ5)
Conductance (PUÆmmHg)1) 0Æ24 (0Æ09) 0Æ26 (0Æ10) 0Æ30 (0Æ17)
Heart rate (BPM) 64 (12) 60 (10) 57 (8)*
Values are mean (SD).
DLCO, pulmonary diffusion capacity for carbon monoxide; KCO: Transfer coefficient for carbon
monoxide; MAP, mean arterial pressure; MST, mean surface temperature.
*Significantly different from baseline.
Significantly different from postexercise.
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gender differences in this response is not known. There was no
difference in the baseline DLCO, MST or CVC before exercise on
the 2 days. The reduction in DLCO 90 min after exercise was the
same on the 2 days, without any changes in thermal status or
cutaneous conductivity. This observation itself, before the
cooling procedure, indicates no influence of skin surface
temperature and blood flow on the post-exercise reduction in
DLCO in this experiment.
The cooling procedure resulted in a reduction in skin
temperatures and perfusion without changes in blood pressure,
rectal temperature or heart rate 105–120 min after exercise. In
the control experiment, thermal status and skin perfusion
remained unchanged 120 min after exercise. There was no
effect of the cooling procedure on DLCO. To lower the surface
temperature, the subjects were exposed to air cooling. The
cooling procedure was not standardized with respect to ambient
temperature and time as a climate chamber was not available.
Other procedures that can more easily be standardized like
immersion of hands and feet in cold water is associated with
sympathetic activation and a reduction in DLCO possibly owing
to increased pulmonary vascular resistance (Frans et al., 1994).
There was no indication of sympathetic activation with
increased heart rate and blood pressure after the cooling
procedure in this study.
The interval between exercise and the first postexercise
measurement of DLCO was 90 min. Most of the postexercise
reduction in DLCO takes place between 60 and 120 min after
exercise and remains for at least 6 h (Sheel et al., 1998). The
cooling procedure could then have attenuated an ongoing
further reduction in DLCO, but there was no further reduction in
DLCO between 90 and 120 min postexercise in the control
situation. DLCO is also influenced by haemoglobin concentration
and repeated tests increasing the CO concentration in the blood.
Fluid intake was standardized during the postexercise period,
and the number of DLCO tests was the same in the control
experiment as in the cooling experiment.
Skin cooling induced a decrease in CVC. As the resistance in
cutanous blood vessels increases, a smaller proportion of cardiac
output will be distributed to the skin, and it could be
hypothesized that decreased CVC would lead to redistribution
of blood volume and increased central blood volume that would
influence DLCO. It could be that the blood volume in cutanous
vessels already is small under thermoneutral conditions, and that
cooling would not influence pulmonary capillary blood volume
to an extent that would have an effect on DLCO. A reduced
intrathoracic blood volume could be attributed to the redistri-
bution of blood volume to organs recovering after exercise.
Increased blood volume has been demonstrated in recovering
thigh muscle by bioimpedance measurements and radioactively
labelled erythrocytes, but not to an extent that could explain the
whole reduction in intrathoracic blood volume (Hanel et al.,
1997). Wilson et al. (2007) have shown that whole body skin
cooling induces a visceral vasoconstriction. This should then add

























































Figure 1 Changes in mean surface temperature, cutaneous vascular
conductance and diffusion capacity of the lung for carbon monoxide.
Bars represent means, error bars show 1 SD. Filled bars show results
from experiment with skin surface cooling and shaded bars show results
from control.
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The laser-Doppler method used for cutaneous flowmetry can
only measure perfusion in about 1 mm3 skin tissue per probe
(Braverman, 1997). The regional differences in cutaneous
perfusion and temperature are large (Wardell et al., 1994;
Hafner et al., 2007). Ramanathan (1964) showed that the four
probes placed on the chest and extremities are adequate for
evaluating MST by weighting contribution from each site. Skin
temperature is closely related to cutaneous perfusion (Nilsson,
1987) and both measurements were integrated in the same
probe. Whether the same weighting procedure is valid for the
estimation of mean cutaneous perfusion is not known. We
calculated the mean cutaneous perfusion and conductance as the
mean of the registrations including the probe placed in the face.
Capillary blood flow is related to arterial blood pressure
(Johnson & Wayland, 1967), and therefore, we calculated
CVC from mean cutaneous perfusion and mean arterial pressure.
The pattern of changes at all five sites was the same in both the
control and cooling experiment.
Systemic haemodynamics in the late recovery phase after
exercise is characterized by an increase in systemic vascular
conductance and a reduction in the mean arterial pressure
(Halliwill, 2001; Lynn et al., 2007), while heart rate and cardiac
output may be elevated or unchanged (Lynn et al., 2007). There
is a reduced vascular responsiveness to sympathetic stimuli
(Halliwill et al., 1996, 2003), and the cooling procedure did not
induce a pressor response. The postexercise haemodynamic
response is modulated by oestrogen and progesterone and is
under the influence of the menstrual cycle. That could explain a
lower reduction in DLCO in women.
We conclude that the postexercise reduction in DLCO in
young well–trained subjects is present when thermal status is
restored after exercise, and that any redistribution of blood
volume by skin surface cooling is not large enough to affect
DLCO in the late recovery phase after exercise.
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Rationale: Data on the change in diffusion capacity of the lung for carbon monoxide (DLCO) over time are
limited. We aimed to examine change in DLCO (DDLCO) over a 9-year period and its predictors.
Methods: A Norwegian community sample comprising 1,152 subjects aged 1873 years was examined in
1987 and 1988. Of the 1,109 subjects still alive, 830 (75%) were re-examined in 1996/97. DLCO was measured
with the single breath-holding technique. Covariables recorded at baseline included sex, age, height, weight,
smoking status, pack years, occupational exposure, educational level, and spirometry. Generalized estimating
equations analyses were performed to examine relations between DDLCO and the covariables.
Results: At baseline, mean [standard deviation (SD)] DLCO was 10.8 (2.4) and 7.8 (1.6) mmol min1 kPa1 in
men andwomen, respectively. Mean (SD)DDLCO was 0.24 (1.31) mmol min1 kPa1.DDLCO was negatively
related to baseline age, DLCO, current smoking, and pack years, and positively related to forced expiratory volume
in 1 second (FEV1) and weight. Sex, occupational exposure, and educational level were not related to DDLCO.
Conclusions: In a community sample, more rapid decline in DLCO during 9 years of observation time was
related to higher age, baseline current smoking, more pack years, larger weight, and lower FEV1.
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D
iffusing capacity of the lung for carbon monoxide
(DLCO) is the most widely used non-invasive test
of pulmonary gas transfer (1). The test has been
used in both clinical and epidemiological settings and
in surveys of occupational groups (28). Several cross-
sectional community studies have presented predictors
for DLCO (917), and commonly used reference values
are based on sex, age, and height. In some cross-sectional
studies, smoking has been found to be associated with
impaired DLCO, while body mass and socioeconomic
status (SES) have been shown to be related to DLCO in
some studies (14, 17). Only two community studies have
been longitudinal in design, which is preferable to cross-
sectional studies when studying change related to ageing
(18, 19).
The two longitudinal studies were an 8-year follow-up
study from Tucson, Arizona (18), including 543 subjects,
and an 8-year follow-up study from Pisa, Italy, including
928 subjects (19). Both studies found that the decline in
DLCO during the follow-up period increased with in-
creasing age, while no relationship to smoking was noted.
The latter is somewhat surprising as smoking is the major
cause of emphysema, which is associated with impaired
DLCO (20). A small cohort study of 84 subjects, followed
for 22 years, has observed smoking to be a predictor for
rapid decline of DLCO (21, 22). The representativity of
this cohort to the population at large is uncertain.
The purpose of this study was to explore predictors for
the longitudinal change in DLCO in a community sample
examined twice 9 years apart. According to previous
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findings in cross-sectional studies of this population
sample (17, 2326), we hypothesized that smoking habits,
occupational airborne exposure, and SES were predictors
of change in DLCO.
Methods
Study population
Details of the sampling and characterization of the study
population have been given elsewhere (27, 28). Briefly, a
stratified sample (n1,512) from the general population
in Hordaland, Norway, aged 1873 years was invited
to a clinical and respiratory physiological examination
in 1987/88. Altogether 1,275 (84%) attended. DLCO
measurements were obtained from 1,152 (90%) of the
1,275 attendees.
All attendees from visit 1 were invited to a follow-up
(visit 2) in 1996/97. From the 1,152 subjects with DLCO
measurements at visit 1, 881 (76%) attended visit 2.
Of those lost to follow-up, 43 were dead, 81 no longer
lived in the study area, 63 did not wish to participate
further, and 23 could not attend because of serious illness.
We were not able to establish contact with 61 of the visit
1 attendees. We obtained DLCO measurements from 830
(94%) of the visit 2 attendees.
Questionnaires
At visit 1, data on smoking habits, educational level, and
occupational airborne exposure were obtained through
self-reported questionnaires (23, 29). Smoking habit was
categorized into never smoking, ex-smoking, and current
smoking. Pack years was calculated as average number of
cigarettes smoked per day, divided by twenty and multi-
plied by total number of years of being a smoker. SES
was assessed in terms of educational level which was
categorized into primary school, secondary school, and
higher education (17).
Occupational airborne exposure was based on the
following data: self-reported past or present occupational
exposure to dust or gas (24) and self-reported exposure
to specific agents and work processes (asbestos, quartz,
wood dust, welding, and soldering) (27).
Clinical examination and pulmonary function testing
Clinical examination included measurements of height
and weight. Blood samples were analyzed for hemoglobin
(Hb) concentration and fraction of carboxyhemoglobin
(HbCO). Pulmonary function testing (PFT), including
DLCO, and forced spirometry were performed in accor-
dance with current guidelines at the time of examination
(1, 3032).
PFT at both visit 1 and visit 2 was performed using
a SensorMedics Gould 2100 automated system (Sensor-
Medics BV, Bilthoven, the Netherlands). The same instru-
ment was used at both visits, with the same calibration
procedure and biological control throughout the observa-
tion period by regular measurements of the technicians
operating the instrument. Details of the standardization
of measurements, calibration processes, and the results
of repeated measurements in the biological controls are
given in the Supplementary file. At both visits, DLCO, the
alveolar volume (VA), and the ratio of DLCO to VA (KCO)
were measured using the single breath-holding method,
with a breath holding time of 10 seconds, a washout
volume of 0.75 L, and a sample volume of 0.75 L. VA was
measured by helium dilution. The test gas was delivered
and certified by Norsk Hydro A/S (Rjukan, Norway). The
concentration of carbon monoxide was requested to be
within 0.270 and 0.330% with an accuracy of 1%. The
concentration of helium was requested to be within 9 and
11% with an accuracy of 1%. The mean of two measure-
ments, with no more than 10% variability, is reported. The
ATS/ERS guidelines require the DLCO measurement to be
performed after the subject had achieved an inspiratory
vital capacity (IVC) of at least 85% of his or her forced vital
capacity (FVC) (27). Only 531 subjects (64%) met this
criterion on both visits, while 750 subjects (90%) achieved
an IVC/FVC ratio of at least 0.7. Excluding the subjects
with an IVC/FVC ratio of less than 0.85 did not alter the
study results overtly as compared to including them in
the analyses (Tables E1 and E2). Hence, the data are
presented including all subjects with an IVC/FVC ratio
0.7. Predicted values for DLCO were calculated using the
formula estimated by Cotes et al. (1). It was decided not to
use Norwegian predicted values, as they are based on the
population sample also used in this study.
Spirometry was performed as an inhalation from
functional residual capacity to total lung capacity,
followed by a maximal forced expiration to residual
volume. For forced expiratory volume in 1 second (FEV1)
and FVC, the highest value from three technically accep-
table measurements, with variability between the two
highest values within 300 mL, is reported. All subjects
were shown how to perform the maneuvers before testing,
using standardized instructions, for both forced spirome-
try and measurement of DLCO. Subjects were seated and
wearing a nose-clip during all efforts. Reference values
calculated from healthy Norwegian subjects were used for
FEV1 (26).
Statistical methods
Descriptive statistics are presented using the mean and
standard deviation (SD) for continuous variables and
frequency and percentage for categorical variables. Com-
parisons of the study population and those lost to follow-
up were performed using the independent samples t-test
and the exact chi-squared test. Comparisons of means
from baseline and follow-up were performed using paired
samples t-test, testing for cohort effect was carried out
using independent samples t-test, and modeling change in
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DLCO as a function of age was performed using curve
estimation. Testing for normal distribution was performed
using the Kolmogorov-Smirnov and the Shapiro-Wilk tests.
DLCO at first and follow-up survey 9 years later
was analyzed in a multiple linear regression model and
estimated with generalized estimating equations (GEE)
to account for correlation between the two measures
of DLCO in the same subject at the two surveys. In this
model, time was given the values 0 and 9 (years), all other
continuous explanatory variables were centered around
their means, all categorical variables were represented
by dummy variables, and all interactions between the
explanatory variables (categorical and continuous) were
included. From such a model, the estimated regression
coefficients for the interactions give direct estimates of the
average yearly change in DLCO from the first to the last
visit (DDLCO) at the zero level for all explanatory variables
(for continuous variables this is the mean value; for
categorical variables it is the reference category), and for
a value of 1 unit increase from 0 in each variable all others
were fixed at 0. For the GEE estimation, an exchangeable
correlation structure was assumed.
Models with adjustments for change in Hb and HbCO
were also made. Finally, we decided a priori to test the
following interactions: age versus sex, age versus smoking
habits, and sex versus smoking habits. A significance level
of 5% was used for all analyses.
SPSS version 20 (IBM Corporation, New York, USA)
was used for all analyses except for the GEE estimation
for which Stata version 12 (StataCorp, College Station,
Texas, USA) was applied.
Results
Study population description
The characteristics of those examined at baseline and
at follow-up and those lost to follow-up are outlined in
Table 1. Almost half of the sample was ever-smokers, and
approximately one quarter of the subjects was current
smokers. Those who were lost to follow-up were signifi-
cantly older and had significantly lower lung function than
those who remained in the study.
Analyses were performed to discover a cohort effect, if
present, by comparing baseline FEV1 and DLCO values of
those aged 4044 years at baseline with the corresponding
follow-up values of those aged 4044 years at visit 2.
Analyses were performed independently for men and
women to adjust for difference in the ratio between the
sexes in these sub-samples. There were no statistically
significant differences in mean values of FEV1 and DLCO.
Table 1. Descriptive statistics for characteristics at baseline and follow-up of the stratified sample from the general population in




Variable n1,152 n830 n322
Sex (male), n (%) 590 (51.2) 436 (52.5) 154 (47.8)
Age (years), mean (SD) 41.6 (16.0) 49.8 (14.4) 44.4 (19.3)
Height (cm), mean (SD) 171.8 (9.3) 172.1 (9.4) 170.1 (9.3)
Weight (kg), mean (SD) 71.4 (12.8) 75.9 (13.9) 69.7 (12.1)
Smoking habits, n (%)
Daily smokers 310 (26.9) 233 (24.7) 77 (23.9)
Ex-smokers 207 (18.0) 149 (21.8) 58 (18.0)
Never smokers 635 (55.1) 448 (53.5) 187 (58.1)
Pack years smoked,a mean (SD) 12.7 (11.1) 16.1 (12.3) 13.7 (14.1)
Occupational exposure, n (%) 337 (29.3) 259 (31.2) 78 (24.2)
Education level, n (%)
Primary school 213 (18.5) 133 (16.0) 80 (24.8)
Secondary school 714 (62.0) 532 (64.1) 182 (56.5)
Higher education 225 (19.5) 165 (19.9) 60 (18.6)
FEV1 (L), mean (SD) 3.60 (1.02) 3.28 (0.96) 3.33 (1.12)
FEV1 percent predicted, mean (SD) 95 (14) 92 (15) 92 (16)
DLCO (mmol min1 kPa1), mean (SD) 9.37 (2.53) 9.35 (2.61) 8.81 (2.67)
DLCO percent predicted, mean (SD) 94 (15) 98 (18) 91 (17)
SD, standard deviation; FEV1, forced expiratory volume in 1 second; DLCO, diffusing capacity of the lung for carbon monoxide.
aNon-smokers excluded.
Predictors for longitudinal change in DLCO
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Baseline DLCO
Mean DLCO at baseline for the entire cohort (n1,152)
was 9.37 mmol min1 kPa1 (SD: 2.53). Using multiple
linear regression, we found that female sex, higher age,
current smoking, ex-smoking, and increased pack years
were associated with lower DLCO. Higher body height,
larger weight, and higher FEV1 were significantly asso-
ciated with higher baseline DLCO, as was higher education
compared to secondary school. Occupational airborne
exposure was not associatedwith baseline DLCO regardless
of whether the exposure characterization was based on
self-reported dust or gas or self-reported exposure to
specific airborne agents (Table 2, and Tables E3 and E4).
Change in DLCO
Mean DLCO at follow-up (n830) was 9.35
mmol min1 kPa1 (SD: 2.61). Baseline DLCO for the
same 830 participants was 9.59 mmol min1 kPa1 (SD:
2.44). Mean DDLCO between baseline and follow-
up for those who attended both visits was 0.24
mmol min1 kPa1 (95% CI: 0.33 to 0.15).
Mean change in DLCO percent of predicted values
for those subjects who attended both visits was 3.0%
(95% CI: 2.3 to 4.1). Mean change in FEV1 percent of
predicted values for the same subjects was 3.0% (95%
CI 3.9 to 2.7).
DDLCO had a normal distribution, tested by both the
Kolmogorov-Smirnov and the Shapiro-Wilk tests, with
a large variation (Fig. 1). Approximately 40% had a
decline of more than twice the average, while 5% had no
change (090.10 mmol min1 kPa1), and 38% had an
increase (0.10 mmol min1 kPa1).
Univariate associations using GEE, adjusting only for
baseline DLCO and change in Hb concentration and
HbCO, were found for age, height, baseline FEV1,
smoking habits, and pack years.
The multivariate analysis, including baseline DLCO,
sex, age, baseline height, baseline weight, baseline FEV1,
baseline smoking habits, pack years smoked before base-
line, occupational exposure, and educational level, showed
that higher baseline DLCO and age were associated with
a more rapid decline in DLCO. Current smokers had a
more rapid decline than never smokers, and increased
pack years was associated with more rapid decline as well.
Higher body height and weight, and higher FEV1 were
associated with a lower rate of decline in DLCO. All the
associations above persisted after adjusting for change in
Hb and HbCO. Sex, occupational exposure to gas or dust,
and level of education were not significantly associated
with DDLCO in the multivariate analyses (Table 3).
We found no interactions between age and sex, age and
smoking habits, or sex and smoking habits on change in
DLCO.
Mean alveolar volume (VA) was 6.49 L (SD: 1.30) at
baseline and 6.29 L (SD: 1.38) at follow-up. There was a
significant reduction in VA during the observation period.
In a multivariate analysis, higher baseline VA and female
sex were significant predictors of a more rapid decline in
VA (Table E5).
Mean carbon monoxide diffusion coefficient (KCO)
at baseline was 1.48 mmol min1 kPa1 L1 (SD: 0.25)
and 1.49 mmol min1 kPa1 L1 (SD: 0.32) at follow-
up. When analyzing the values from only the partici-
pants who met the requirement of an IVC/FVC ratio
of 0.85 or above, the corresponding means were
1.45 mmol min1 kPa1 L1 (SD: 0.24) and 1.46
mmol min1 kPa1 L1 (SD: 0.28), respectively. When
analyzed in a multivariate model, we found that higher
baseline KCO, male sex, higher age, lower baseline body
weight, current smoking, higher number of pack years
smoked, and lower level of education were significant
predictors of a more rapid decline in KCO (Table E6).
Discussion
In this 9-year follow-up study of a general population
sample, we observed that the rate of decline in gas
diffusion capacity was highly variable. Mean change in
DLCO was 0.025 mmol min1 kPa1 year1. Cur-
rent smoking was the strongest predictor for decline in
DLCO. In addition, older age, higher cumulative smoking
consumption in terms of pack years, lower level of
FEV1, lower body weight, and shorter body height were
independent predictors of increased DLCO loss. Sex,
educational level, and occupational airborne exposure
did not independently influence change in DLCO.
This is the first community study to show that current
smoking status and previous smoking consumption in
terms of pack years predict loss of DLCO. The study is
also the first to examine the effect of educational level
and occupational airborne exposure on change in gas
diffusion capacity. Our study confirms the findings of
others (18, 19) that the decline in DLCO becomes more
rapid with higher age.
The magnitude of the decline in DLCO observed in our
study is comparable to that found by Viegi et al. (19),
while comparison to the decline found by Sherrill et al.
(18) is more complicated because of differences in how
the results are reported. Standard error of the mean of
DLCO seems to be comparable between all three studies.
Current smoking was related to a reduced baseline
DLCO and a larger subsequent decline in DLCO in the
multivariate analyses. Adjusting for HbCO did not change
this association. Hence, current smoking has an effect
on level and decline of DLCO beyond that of previous
exposure and that of HbCO. Smokers more often develop
anemia that may impair gas diffusion (33). However, when
change in Hb was added to the equation, the relationship
between smoking and DLCO persisted. The study was not
designed to investigate mechanisms by which tobacco
smoke could alter the rate of change in DLCO.
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Cumulative smoking exposure in terms of pack years
was also an independent predictor of future decline in
DLCO (Table 3). There may be several explanations for
this finding. First, smoking exposure may cause airflow
limitation and air trapping that lead to impaired gas
diffusion capacity. However, the effect of pack years on
DLCO decline persisted after taking baseline FEV1 into
account (Table 3). Second, we have recently shown in
Table 2. Descriptive statistics for baseline DLCO in 1987/88 and average change per year during a 9-year follow-up, DDLCO, for
830 subjects from Hordaland County, Norway, according to baseline characteristics
Characteristics at baseline Baseline DLCO (mmol min1 kPa1), mean (SD) DDLCO (mmol min1 kPa1 year1), mean (SD)
Sex
Male 10.85 (2.38) 0.039 (0.161)
Female 7.83 (1.57) 0.010 (0.114)
Age in years
Up to 19 10.60 (2.39) 0.003 (0.158)
2029 10.88 (2.49) 0.021 (0.150)
3039 10.00 (2.20) 0.001 (0.129)
4049 9.45 (2.10) 0.037 (0.163)
5059 8.23 (2.01) 0.032 (0.134)
6069 7.54 (1.69) 0.072 (0.103)
7079 6.02 (1.46) 0.050 (0.122)
Height in cm
159 and below 6.55 (1.27) 0.023 (0.118)
160169 7.90 (1.61) 0.018 (0.103)
170179 9.93 (1.97) 0.030 (0.142)
180189 11.62 (2.31) 0.034 (0.192)
190 and above 12.84 (2.16) 0.005 (0.154)
Weight in kg
49 6.08 (1.80) 0.001 (0.114)
5059 7.76 (1.64) 0.016 (0.111)
6069 8.83 (2.24) 0.026 (0.120)
7079 10.06 (2.54) 0.041 (0.156)
8089 10.48 (2.41) 0.001 (0.150)
9099 10.61 (2.44) 0.034 (0.207)
100 10.78 (2.89) 0.049 (0.118)
Smoking habits
Never smoker 9.62 (2.62) 0.012 (0.144)
Ex-smoker 9.20 (2.31) 0.037 (0.119)
Daily smoker 8.99 (2.43) 0.044 (0.148)
Pack years smoked
0 9.62 (2.62) 0.012 (0.144)
120 9.23 (2.40) 0.031 (0.136)
2140 8.75 (2.19) 0.080 (0.137)
40 6.79 (1.92) 0.094 (0.125)
Occupational exposure
No 9.08 (2.32) 0.019 (0.138)
Yes 10.12 (2.53) 0.029 (0.152)
Education level
Primary school 8.15 (2.22) 0.041 (0.131)
Secondary school 9.43 (2.44) 0.023 (0.144)
Higher education 10.37 (2.62) 0.020 (0.143)
FEV1 quartiles
2.89 L and below 6.87 (1.51) 0.031 (0.109)
2.903.55 L 8.56 (1.27) 0.030 (0.125)
3.564.36 L 9.95 (1.66) 0.014 (0.145)
4.37 and above 12.20 (1.95) 0.029 (0.174)
DLCO, diffusing capacity of the lung for carbon monoxide; FEV1, forced expiratory volume in 1 second; SD, standard deviation.
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another data set that level of emphysema is related to
DLCO after adjusting for FEV1 (34). Hence, increased
smoking consumption may cause decline in DLCO
because of more emphysema.
Neither the Italian nor the American community study
observed that current smoking or smoking consumption
was related to decline in DLCO (18, 19). The follow-up
rate in the Italian study was lower than that in the current
study, and smokers tend to drop out more often than
non-smokers in longitudinal surveys (35). The American
study comprised only about half the number of subjects
of our study and they had no subjects above the age of
59 years at baseline (18).
In line with others (18, 19), we observed that the DLCO
decline becomes more rapid with increasing age. The best
fit of the model was for age squared, adding further
support to our finding that the decline accelerated with
increasing age. In the multivariate analysis, this accelera-
tion in the decline with increasing age was found to be
independent of smoking, lung function, body height and
weight, as well as occupational exposure and SES.
Potential explanations might be age-related reduced al-
veolar ventilation, increased level of emphysema, increased
pulmonary blood pressure, and impaired cardiac function
(36).
When comparing DLCO with available European
predicted values, we observed an increase in the percent
predicted value while there was a decrease in the absolute
value. These predicted values were based on a compila-
tion of European cross-sectional studies, and the age
coefficient may be overestimated because of a cohort
effect and less precise characterization of the subjects
with respect to symptoms, previous smoking, and occu-
pational exposure. As for FEV1, the annual change in
longitudinal studies is less than the estimated annual
change from cross-sectional surveys.
The difference between cross-sectional and longitudi-
nal estimates of annual change may also be influenced by
regression to the mean. We included baseline DLCO in the
model which will partially account for that phenomenon.
We did not observe that occupational airborne exposure
influenced level of DLCO or decline of DLCO in this general
population sample. This may imply that there is no impact
of occupational exposure on gas diffusion capacity in a
community setting, or that we have not been able to
show it. Regarding the latter possibility, the exposure
Fig. 1. The distribution of change in DLCO during a 9-year follow-up from 1987/88 in 830 subjects from Hordaland County,
Norway.
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characterization applied in the present study has been
used to show a relationship between lung function in terms
of spirometry (27, 37), diagnosis of asthma and chronic
obstructive pulmonary disease (27, 38), as well as the
prevalence and incidence of respiratory symptoms (24, 38).
The exposure data have a high specificity, but a lower
sensitivity (29). Those stating exposure have in general
been exposed to a higher degree than those falsely stating
no exposure (29). Hence, we think that our study indicates
that the level of occupational exposure in a general
population sample is not high enough to cause impaired
level of DLCO and more rapid decline in DLCO.
We have previously shown in cross-sectional analyses
in this population that lower SES in terms of educational
achievement is independently related to reduced level
of DLCO (17). However, we did not observe that SES
predicted subsequent change in DLCO after adjusting for
the other covariates. As people tend to stay in the
socioeconomic class into which they are born, the effect
of SES on DLCO may have been evident at an early stage
in life after which the subsequent decline in DLCO is
independent of SES. However, it should be noted that low
as compared to high SES was an independent predictor
of rapid decline in KCO (Table E6).
Strengths and limitations of the study
This study is based on a community survey with high
response rates both at baseline and follow-up. The study
sample is representative of the population at large with
respect to sex, age, and smoking (25, 35). Except for
the requirement of an IVC/FVC ratio above 0.85, the
participants included in the analyses met the ATS-criteria
for a satisfactory DLCO test (28). The same equipment for
measuring DLCO was used at baseline and follow-up with
the same technicians. The effect of smoking on change in
DLCO was adjusted for by change in HbCO, and finally
validated questions on occupational exposure were used.
There are also some limitations to the study. First,
we had only two points of observations, rendering the
study susceptible to regression towards the mean. On the
other hand, we adjusted for baseline level of DLCO, which
should at least partly take this bias into account. Second,
we did not have data on menstrual cycle for female
participants, and are therefore not able to adjust for the
effects of the menstrual cycle on DLCO (3941).
In conclusion, we have observed that in the population
at large both current smoking and cumulative smoking
exposure, reduced FEV1, and increasing age predict more
rapid decline in gas diffusion capacity, while occupational
exposure and SES do not. This knowledge may help
physicians in their interpretation of DLCO measurements.
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